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Abstract 
Small molecules that bind to any predetermined DNA sequence in the human 
genome are potentially useful tools for molecular biology and human medicine. 
Polyamides containing N-methylimidazole (lm) N-methylpyrrole (Py) are cell permeable 
small molecules that bind DNA according to a set of "pairing rules" with affinities and 
specificities similar to many naturally occurring DNA binding proteins. Py-Im 
polyamides offer a general approach to the chemical regulation of gene expression. We 
demonstrate here that polyamide containing a DNA alkylating moiety seco-CBI can 
specifically direct sequence specific DNA alkylation. We can also control the strand of 
DNA that is alkylated, depending on the enantiomer of seco-CBI used and the orientation 
of the polyamide relative to the alkylation site (Chapter 2). This class of molecules has 
been applied to a gene repair system in collaboration with the Baltimore group at Caltech 
(Chapter 3). Also reported are additional seco-CBI polyamide conjugates synthesized to 
study other systems (HIV -1 and COX-2) (Appendix 1 ). 
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Expression of Genetic lnformationfrom DNA 
DNA is the universal storage material for genetic information in all living 
organisms. The flow of genetic information starts with DNA, which is transcribed into 
RNA, and the RNA is then translated to proteins. DNA serves as the permanent storage 
material in the cell, while RNA is a transient copy of this genetic information and is 
synthesized as necessary. Proteins serve to perform specific functions such as signaling 
or maintenance in the cell, and like RNA, are often synthesized as needed and then 
degraded. It is remarkable, then, that all the genetic information essential to sustaining 
living organisms is present in the form of DNA and that copies of this DNA are present 
in every living cell. 
Specific protein-DNA interactions are fundamental pieces of cell differentiation. 
For although almost all cells contain identical genetic information, the selective 
transcription of certain genes but not others allows a neural cell in the brain to function 
differently than an epithelial cell in the skin. 1 Transcription factors are DNA binding 
proteins that regulate transcription by recruiting the necessary transcriptional machinery. 
Typically, the promoter region of a gene contains the recognition sites of the required 
transcription factors. Upon binding, the transcription factor recruits a network of more 
than fifty proteins that are required to initiate active transcription. This multi-protein 
complex has a molecular weight of more than two million, and contains all the proteins 
necessary for activated transcription to occur.2 The process of transcription elongation is 
just as complex, as more than 20 protein subunits that comprise RNA polymerase II must 
track along the DNA and synthesize the complementary RNA. Unlike in DNA synthesis, 
3 
transcription elongation occurs in fits and starts, with elongation factors necessary to start 
the polymerase complex again once it has paused.3.4 
+I 
Transcription Complex 
> 2,000,000 MW 
L. 
Figure 1.1. Model of protein regulation of gene transcription. 
DNA as a paradigm for small molecule recognition 
Because DNA plays a fundamental role in gene expression in the cell, a general 
code for sequence specific DNA recognition is desirable for the design of new drugs that 
manipulate gene expression.5 Much of the work in this field is based on protein:DNA 
interactions which are characterized by hydrogen bonds, van der Waals interactions and 
electrostatic interactions. To date, no all-purpose code of amino acid/DNA recognition 
has been developed due to the diverse recognition and structural motifs found among 
DNA-binding proteins.6 
To develop general rules for sequence specific DNA recognition by small 
molecules, a careful examination of DNA structure is required. Double helical DNA 
consists of two anti parallel strands that fit together in a right-handed helix.7 DNA can be 
characterized as having three domains: the sugar/phosphate backbone, the major groove, 
and the minor groove. The deoxyribose and phosphate esters form a unique charge 
pattern along the helix backbone. Protein side chains often make electrostatic 
interactions with the sugar/phosphate backbone, but such interactions tend not to be 
sequence specific. 
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The nature of DNA helix dictate the characteristic structures of the major and 
minor grooves, the major groove being wider and shallower, and the minor groove being 
narrower and deeper. The edges of the base pairs in the Watson-Crick hydrogen bond 
pairings result in the unique hydrogen bonding faces of the major and minor groove.7 For 
a T• A base pair, in the major groove there is a pattern of hydrogen bond acceptor (lone 
pairs on 04 of thymine), and hydrogen bond donor (NH of exocyclic amine of adenine). 
The minor groove of a T• A base pair forms a pattern of two hydrogen bond acceptors 
(02 of thymine and N3 of adenine). Likewise, for a C•G base pair, the major groove can 
be characterized as having a hydrogen bond donor (NH of exocyclic amine of cytosine) 
and a hydrogen bond acceptor (06 of guanine). The minor groove of a C• G base pair has 
a hydrogen bond acceptor (02 of cytosine), hydrogen bond donor (NH of exocyclic 
amine of guanine) and a hydrogen bond acceptor (N3 of guanine) (Figure 1.3). In the 
minor groove, it is the exocyclic amine of guanine that primarily distinguishes an A•T 
base pair from a G•C base pair. 
3' 5' 
Figure 1.2. B-form double helical DNA. Antiparallel strands arc ind icated in dark and light gray. (left) 
space fill ing CPK model. (right) ribbon representation. 
Major Groove 3' 5' Major Groove 
Minor Groove Minor Groove 
5' 3' 
Figure 1.3. A schematic model for recognition of the minor groove, with hydrogen bond donors 
represented as (H) and hydrogen bond acceptors represented as two dots. 
5 
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Sequence Specific DNA binding by Distamycin and 2-Imidazole Netropsin 
In addition to proteins, there are many classes of natural products that are able to 
bind to DNA in a sequence specific manner. Some examples of such molecules are 
chromomycin, distamycin, actinomycin D, and calicheamicin oligosaccharide (Figure 
1.4).8- 11 These molecules either bind in the minor groove, or intercalate between the base 
pairs. Because of their size they have short DNA recognition sequences, and their 
interactions could be compared to those of protein side chains. 
Chromomycin • 5'-GGCf-3' 
Actinomycin D • 5'-GC-3' Calicheamicin oligosaccharide • 5'-TCCf-3' 
Figure 1.4. Chemical structures of natural products that bind DNA. 
Distamycin is distinct from most DNA binding natural products only by its 
simplicity. It consists of three N-methyl carboxamide units and contains no chiral 
centers. This crescent shaped molecule binds in the minor groove of DNA, preferentially 
at A-T rich regions. The crystal structure of distamycin bound to a DNA duplex showed 
that the carboxamides make specific hydrogen bonds to the bases in the minor groove. 11 
The Dervan group has pursued distamycin as the starting point to base the discovery of 
small molecules that regulate transcription. 12 
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An early lead in attempts to generate a general code for DNA recognition was the 
discovery of 2-irnidazole netropsin. It had been suggested that the imidazole ring of this 
compound would make a specific hydrogen bond to a G• C base pair and that 2-imidazole 
netropsin would target the sequence 5'-GWWW-3'. Footprinting experiments showed 
that unexpectedly, 2-imidazole netropsin instead bound the site 5 '-WGWCW-3' . The 
two-fold symmetry of the binding site was puzzling since it suggested that there was not 
a single binding orientation for 2-imidazole netropsin. Earlier studies of 
distamycin!DNA complexes gave an interesting solution to this discrepancy. Distamycin 
was found to have two very distinct binding modes. In the first, a single molecule of 
distamycin binds in the center of the minor groove of A-T rich DNA. The amide 
hydrogens form bifurcated hydrogen bonds to the N3 of adenine and 02 of thymine on 
the floor of the minor groove. In the second binding mode, distamycin binds as an 
anti parallel, side-by-side dimer in the minor groove. Instead of the bifurcated hydrogen 
bonds of the 1:1 complex, each strand of DNA forms hydrogen bonds with one molecule 
of distamycin. Using this 2: 1 binding model for 2-imidazole netropsin explained why its 
preferred binding site is symmetrical (because it binds as a side-by-side antiparallel 
dimer) and does not match the predicted site. 13•14 
5' 3' 
I: I Distamycin•DNA Complex 2:1 Distamycin•DNA Complex 
Figure 1.5. A schematic representation of recognition of A,T rich sequences in the minor groove by I: I 
and 2: I complexes of Distamycin. 
The Hairpin Motif of Pyrrole-lmidazole Polyamides 
The affinity of the dimer 2-imidazole netropsin was still modest (micromolar 
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binding constants) in comparison to DNA binding proteins (nanomolar or higher binding 
constants). To decrease the en tropic factors influencing binding, two molecules of 2-
imidazole netropsin were connected in a head to tail fashion with an alkyl linker, y-
amino-butyric acid (y). 15 The resulting 'hairpin' -like structure yielded a compound with 
increased affinity for the binding site 5'-WGWCW -3' of -100 fold. Connecting the two 
distamycin-like components also allowed for the design of heterodimeric polyamides to 
target asymmetric sequences. As an example, the compound ImPyPy-y-PyPyPy was 
found to target the sequence 5'-WGWWW -3'. The hairpin motif for this compound was 
found to increase the binding affinity by 400-fold (Figure 1.6). 
ImPyPy-Dp I PyPyPy • TGTT A 
Ka- 2 X 105 M·1 
Figure 1.6. Example of the hairpin polyamide motif. 
ImPyPy-y-PyPyPy-Dp • TGTT A 
Ka = 8 X 107 M· 1 
Pairing Rules for Pyrrole-Imidazole Polyamides 
The results of 2-imidazole netropsin binding to the site S'WGWCW-3' as an 
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anti parallel dimer and the development of the hairpin motif allowed us to design a set of 
pairing rules for recognition by pyrrole (Py) and imidazole (lm) amino acids16 (Figure 
1.7). A Pyllm pair targets a C• G base pair while an lm/Py pair targets a G• C base 
pair. 17·18 The basis for discrimination of a G• C base pair is from the formation of a 
hydrogen bond between imidazole N3 and the exocyclic amine of guanine.19·20 A Py/Py 
pair is partially degenerate and recognizes both A•T and T•A base pairs. 13·17· 18·21.22 High 
resolution NMR and crystal structures have confirmed that specific hydrogen bonds are 
made from the carboxamide nitrogens to the base pairs and the imidazole nitrogen to 
guanine. 
To address the question of A•TIT• A degeneracy by a Py/Py pair, N-methyl-3-
hydroxypyrrole (Hp) was synthesized and incorporated into a polyamide.23·24 Hp places a 
10 
hydroxy group in the asymmetric cleft between a thymine and adenine base pair. Thus, an 
Hp/Py pair recognizes the sequence T • A and a Py!Hp pair recognizes an A• T base pair 
(Figure 1.7). The binding of Hp has also been confirmed by a high resolution crystal 
structure, and shows that the hydroxy group of Hp binds in the asymmetric cleft as 
designed and also makes two hydrogen bonds to 02 of thymine.25·26 
Figure 1.7. Binding model for the complex formed between fmepmymymy-y-fmepmymymy-~-ap and the 
DNA duplex 5'-TGITACA-3'. Hydrogen bonds are shown as dashed lines. 
Other polyamide motifs 
The development of a solid phase methodology to synthesize Py-Im polyamides 
has greatly facilitated the examination of other motifs and analogues of polyamides.27 
Another modification to the hairpin structures is the use of a chiral turn (Diamino-butyric 
acid, DABA) which influences the binding orientation of the polyamide and increases 
affinity and specificity.28 Extension of the binding site size was achieved by the addition 
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of more Py or Im rings to the hairpin. In order to target sequences of more than six to 
eight base pairs, an aliphatic ~-alanine residue E~F can be used.29. 32 The crystal structure 
of a Py-Im polyamide shows that the helical pitch of the polyamide is slightly greater 
than the pitch of the DNA helix.20 Thus to target longer sequences, ~is added to 
compensate for these sequence composition effects. Using these modifications, it is 
possible to design polyamides having subnanomolar binding constants, on par with those 
of DNA binding proteins. Examples of other polyamide motifs such as cycles33·34, tandem 
hairpins35, and cooperative dimers3637 are shown in Figure 1.8. 
5'- T G T A C A- 3' 5'-T G T T A T T G T T A-3' 
~
3'- A C A T G T- 5' 3'-A c A A T A A C A A 
6 bp 11 bp 
5'- T G T G A A C A- 3 ' 5'-A G G G A T T c c c T-3' 
~
Y-A C A C T T G T-S 3'- T c c c T A A G G G A-5' 
8 bp 11 bp 
S-A G C A G C T G C q-~ 
~~
5'-A T A A G C A G c T G c T T T T T-3' 
Y-T C G T C G A C G A-5' 3'-T A T T c G T c G A c G A A A A A-5' 
10 bp 16 bp 
Figure 1.8. Representative motifs for polyamide: DNA recognition. Shaded and unshaded circles represent 
imidazole and pyrrole residues, respectively. ~-alanine and they-turn are represented as a diamond and 
curved line, respectively. The plus sign represents the dimethylaminopropylamide tail or the a-amino-y-
turn. 
Applications of Py-Im Polyamides in Transcription Inhibition and Activation 
As a proof of principle that small molecules can regulate transcription, Py-Im 
polyamides were designed for use in two transcription systems. For the first system, two 
polyamides were designed to inhibit the binding ofT AT A-binding protein (TBP) and 
LEF-1 , two essential transcription factors that bind in the promoter region of HIV -1.29 
Individually, each was shown to inhibit HIV -1 transcription between 60% and 80%. 
However, together the two polyamides showed synergistic effects and reduced HIY -1 
transcription to undetectable levels in cell culture. This experiment showed that Py-Im 
polyamides are cell permeable, and are capable of inhibiting transcription through 
rational design to targeted sequences. 
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A second system used a constructed promoter to see if polyamides were capable 
of activating transcription.38 The polyamide fmmymymy-y-mymymymy-~-ap was coupled to 
a known transcriptional activator peptide. A promoter with six match sites for the 
polyamide-peptide conjugate was placed 40 base pairs upstream from the TAT A box. Up 
to 40-fold activation of transcription was observed over basal levels with these 
conjugates. These experiments show that polyamides can be used to manipulate a variety 
of transcriptional processes, and point the way to other experiments using small 
molecules that sequence specifically bind to DNA. 
Scope of this Work 
Sequence Specific DNA Alkylating Agents 
Py-Im hairpin polyarnides are small molecules that are cell permeable and capable 
of inhibiting transcription in in vivo systems through sequence specific DNA interactions. 
Thus far, the methods explored for transcription inhibition by polyamides have focused 
on preventing the binding of essential transcription factors in the promoter region. In 
unpublished work, we have found that when polyamides are targeted to the coding region 
of specific genes, no inhibition of transcription is observed. The noncovalent interactions 
between the polyamide and DNA are not strong enough to stop the progression of RNA 
polymerase. We were interested in addressing the question of whether bifunctional DNA 
13 
binding polyamides that covalently interact with the minor groove of DNA could inhibit 
polymerase elongation. The generation of a sequence specific DNA alkylating agent 
would introduce a new class of gene specific 'knockout' agents that would be useful for a 
variety of biological disciplines. 
Chapter 2 describes efforts to develop a sequence specific alkylating agent using a 
hairpin polyamide-seco-CBI conjugate. CBI is an analogue of the natural product CC-
I 065, and alkylates DNA in the minor groove at N3 of adenine. Hairpin polyamides 
modified with seco-CBI off the y-amino-butyric acid turn were synthesized to deliver the 
alkylating moiety to adenines adjacent to the polyamide binding site. Applications of 
these polyamide conjugates are discussed in chapter 3, through the design of polyamide 
conjugates to study gene repair processes. Appendix 1 describes other polyamide-seco-
CBI conjugates that were characterized to study COX-2 and HIV. 
In this work, the function of hairpin polyamides has been extended to include 
sequence specific covalent modification of DNA in the minor groove. The generality of 
the pairing rules and the knowledge at hand concerning transcription elongation and 
DNA repair processes make sequence specific DNA alkylation a useful approach for the 
study of these systems. 
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CHAPTER TWO 
Strand Selective Cleavage of DNA by Diastereomers of Hairpin 
Polyamide-seco-CBI Conjugates 
The text of this chapter is taken in part from a published paper that was coauthored with 
Prof Peter B. Dervan 
(Chang, A.Y. ; Dervan, P.B. J. Am. Chern. Soc. 2000, L22, 4856-4864) 
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Abstract 
Pyrrole-imidazole polyamides are synthetic ligands that bind predetermined DNA 
sequences with subnanomolar affinity. We report the synthesis and characterization of an 
eight-ring hairpin polyamide conjugated at the tum to both enantiomers of 1-
( chloromethyl)-5-hydroxy-1 ,2-dihydro-3H-benz[e ]indole (seco-CBI), an alkylating 
moiety related to CC-1065. Alkylation yields and specificity were determined on a 
restriction fragment containing six base pair match and mismatch sites. Alkylation was 
observed at a single adenine flanking the polyamide binding site, and strand selective 
cleavage could be achieved based on the enantiomer of seco-CBI chosen. At 1 nM 
concentrations of polyamide-seca-CBI conjugate, near quantitative cleavage was 
observed after 12 hours. These bifunctional molecules could be useful for targeting 
coding regions of genes and inhibition of transcription. 
21 
Design of Polyamide-CBI Conjugates 
The design of sequence specific DNA alkylating agents requires the integration of 
two separate functional moieties for recognition and reaction. As described in chapter 1, 
hairpin Py-Im polyamides are suitable for DNA recognition due to their high affinity and 
specificity for the minor groove of DNA. The reactive moiety must specifically alkylate 
in the minor groove proximal to the hairpin polyamide target site, with covalent reaction 
yields that are near quantitative. In order to maximize stoichiometric reaction on the 
DNA, the 'electrophilic functionality' must be reactive with DNA at 37 °C, be inert in 
aqueous media and buffer components, and not suffer unimolecular decomposition in 
competition with the desired reaction with DNA. The reactive moiety of the natural 
product ( + )-CC-1 065 and its analogues meets these criteria for our design of bifunctional 
molecules for sequence specific alkylation of DNA. 
CC-1065 and Duocarmycins 
CC-1 065 is part of the family of duocarmycins, natural products derived from 
cultures of Streptomyces zelensis. It consists of three substituted benzopyrrole moieties 
linked by amide bonds. It was discovered to be a potent antitumor antibiotic by Upjohn. 
The mode of action was found to be the reactive cyclopropyl moiety on one of the 
subunits that affords sequence specific DNA alkylation at N3 of adenine. 1 This reactive 
moiety is typical of all members of the duocarmycin family (Figure 2.1). Alkylation at 
this position results in a labile base-sugar bond generating an abasic site that leads to 
DNA cleavage. The duocarmycins target Aff rich sequences of DNA. Unlike the case 
of distamycin, the duocarmycins have no amide protons with which to form hydrogen 
bonds to the DNA bases. Therefore, its sequence selectivity is based primarily on van 
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der Waals interactions that are maximized in the narrower AfT minor groove. CC-1065 
once showed great promise as an antitumor agent for treatment of cancer, but its early 
clinical trials revealed delayed toxicity.v However, its mechanisms of action continue to 
be studied and pursued for the discovery of related anticancer drugs. 
OMe 
(+)- CC-1065 
( + )- Duocarmycin A 
Figure 2.1. CC-I 065 and the family of Duocarmycins. 
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A debate has lingered for some time concerning the origin of catalysis for the 
alkylation reaction of the duocarmycins at N3 of adenine.4 The Alkylation Site model 
requires that the selectivities of simple and extended analogues of CC-1 065 are derived 
only from the cyclopropyl moiety. Noncovalent interactions are not considered to have 
significant effect on the alkylation selectivity. This model requires acid dependence to 
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Figure 2.2. (a) Alkylation Site modeL Alkylation reaction is driven by protonation of the carbonyl , 
presumably from a protonated phosphate of the DNA backbone. (b) Illustration of vinylagous amide 
stabi lization in duocarmycins. Stability to nuc leophiles in solution is enhanced by the conjugation of the 
rings systems. 
Dale Boger has argued against this model and suggested the Noncovalent Binding 
model based on work in his group. After studying the acid dependence of alkylation and 
finding that the rate change is negligible over physiologically relevant pH 7 and 8, they 
disregard the idea that the alkylation reaction is acid catalyzed.5 Their models suggests 
that the basis for the stability of the duocarmycins is inherent in the vinylogous amide 
stabilization found in all the members of this family. Crystal structures of the 
duocarmycins, as well as many analogues show that these molecules are planar, a 
conformation that maximizes 1t orbital overlap.6 Additional data from NMR structures 
reveal that when bound to DNA, the compounds are now shown to be bent, meaning that 
the vinylogous amide stabilization is lost.?.S Boger's model states that it is not only the 
reactivity of the electrophilic cyclopropane ring that drives the reaction, but also the loss 
of the vinylogous amide stabilization that occurs upon binding to DNA. Upon binding, if 
a nucleophile (N3 of adenine) is present, the alkylation event occurs. The stability of the 
adduct is further reinforced because retroalkylation via spirocyclization is no longer 
favored because of this conformational change (Figure 2.2b).9 
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The target sequences of ( + )-Duocarmycins A and SA are identical in their 
sequence preference with 5'-AAA-3' as the most preferred site (alkylated base 
underlined).' There is also a preference for A or T over G or C to the 5' side, and a weak 
preference of a purine over a pyrimidine at the 3' side. ( + )-CC-1 065 has a similar 
consensus sequence to the (+)-duocarmycins of 5'-(Aff)(Aff)AAA-3'. It has a longer 5 
base pair binding site because of the additional benzopyrrole subunit. The unnatural 
enantiomers of duocarmycins also alkylate DNA, but typically ten times higher 
concentrations are necessary than the natural enantiomers to see comparable amounts of 
DNA cleavage. The consensus sequences are similar, but the binding orientations are 
reversed, due to the chirality of the reactive cyclopropyl moiety. 
Analogues ofCC-1065 
Many analogues of CC-1065 have been synthesized in attempts to minimize the 
delayed toxicity effects while maximizing DNA alkylation efficiency. One of the early 
analogues synthesized in Dale Boger's group was 1 ,2,9,9a-tetrahydrocyclopropa-[c]-
benz[e]indol-4-one (CBI). 10 Despite the rather significant structural change from CC-
1065 to CBI (Figure 2.3), the alkylation properties of CBI were superior to that of CC-
1065. CBI has proven to be more stable at biologically relevant pH and more potent as 
an alkylating agent than CC-1 065. Because of its simplified structure, it is also more 
readily synthesized. Earlier work had also shown that the seco (ring open) agents had 
indistinguishable DNA alkylation selectivities, efficiencies and biological potencies as 
the cyclopropyl derivatives.'' We chose to use the seco-CBI agents to conjugate to the 
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polyamide because of their easier accessibility and longer shelf lives as well as their 
increased reactivity to DNA. In addition we chose to examine both enantiomers of seco-
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Figure 2.3. Analogues of CC-I 065. 
Selection of Hairpin Polyamide 
The eight-ring hairpin polyamide of sequence composition ImlmPyPy-(Rt2Ny-
fmmymymy-~-ap (1) (Figure 2.4) was designed as the parent polyamide of this series. 
This polyamide had been previously well characterized and targets the match site 5'-
WGGWCW-3'. Polyamide 1 has been shown to target the sequence 5'-TGGTCA-3 ' 
with a K,. of 1.3 x 1010 M'1.12 We chose polyamide 1 because it has been well 
characterized and also because it targets a non-palindromic sequence. For the early 
members of this series of compounds, we wanted to be able to examine the efficiency of 
cleavage without the concerns of more than one binding orientation of the polyamide. 
The polyamide conjugates 2R and 2S are also shown in Figure 2.4. Glutaric acid links 
seco-CBI to the polyamide via the chiral turn. 13 The control compounds 3R and 3S 
(Figure 2.4) incorporate the seco-CBI subunit and a positive charge for solubility. The 
sequence specificity of the seco-CBI conjugates will be determined by comparing 
alkylation patterns and yields to the control compounds. 
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Figure 2.4. (a) Structures of Parent polyamide 1, CBI-conjugates 2R and 2S, and unlinked control 
compounds 3R and 3S. (b) (top) Hydrogen bond model of the polyamide-DNA complex formed by the 
polyamide fmlmmymy-ys·CB f >_gmmymymy-~-ap (2S) bound to the minor groove of 5'-TGGTCA-3'. Circles 
with dots represent lone pairs of N3 purines and 0 2 of pyrimidines. Circles containing an H represent the 
N2 hydrogen of G. Putative hydrogen bonds are illustrated by dotted lines. (bottom) Binding model for 
polyamide fmlmmymy-yR·CBf>_gmmymymy-~-ap (2S) with a 5'-TGGTCA-3' site. Shaded and nonshaded 
circles denote imidazole (lm) and pyrrole (Py) rings, respectively. Diamonds and hatched triangles 
represent ~-alanineE~F and (S)-CBI, respectively. (R)-2,4-diaminobutyric acid (y) and 
dimethylaminopropylamine (Dp) are depicted as a curved line and a plus sign, respectively. 
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Synthesis of Boc-seco-CBI 
Synthesis of Boc protected-seco-CBI 4 was performed according to the 
procedures outlined by Boger in 1995 (Figure 2.5). 14- 16 Briefly, condensation of ammonia 
and l ,3-dihydroxynaphthalene with subsequent Boc protection of the amine and benzyl 
protection of the alcohol yields the protected naphthalene derivative. Treatment with NIS 
provides the iodonapthylamine derivative. Alkylation with allyl bromide provided a 
substrate for a favorable 5-exo-trig aryl radical-alkene cyclization to occur, using Bu3SnH 
and TEMPO radical trap. Cleavage of the TEMPO trap intermediate occurs upon heating 
with activated Zn powder. Treatment with PPh/CC14 followed by deprotection of the 
benzyl ether gave the desired product 4 in racemic form. 
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Figure 2.5. Synthesis of Boc-seco-CBI (4). (i) NH3 (liquid); (ii) Boc anhydride; (iii) benzyl bromide; (iv) 
NIS; (v) allyl bromide, sodium hydride; (vi) TEMPO, Bu1SnH; (vi i) Zn/AcOH; (viii) PPh/CC14 ; (ix) 
HC02NH4, Pd/C. 
Chiral resolution of racemic seco-CBI 4 is accomplished through chiral HPLC 
methods also developed by Boger. 17 Using a semi-preparative column, one can purify 50 
to 100 mg of material over several runs. For the coupling chemistry used for polyamide 
conjugate synthesis, it was found that the secondary amine of 4 (after deprotection) was 
difficult to couple to the polyamide. For this reason, we added a P-a1anine linker which 
couples well to the NHS ester of the polyamide. Synthesis of Boc-(3-ala-seco-CBI 5 is 
illustrated in figure 2.6. Deprotection with HCl/ethyl acetate followed by addition of 
















Figure 2.6. Synthesis of Boc-P-alanine-seco-CBI (SR and SS). (i) ChiraiCcl OD; (ii) 3M HCI/EtOAc, 30 
min; (iii) Boc-P-Aianine, HBTU, DIEA, DMF. 
Synthesis of Polyamide-seco-CBI Conjugates and Unlinked Analogues 
The eight-ring hairpin polyamide 1 was prepared by manual solid-phase peptide 
synthesis. 18 After reverse phase HPLC purification, an NHS-activated glutaric acid 
linker was attatched to the a-amino group on they-turn to afford modified polyamide 1-
DSG. 13 After HPLC purification, the appropriate enantiomer of ()-alanine linked seco-
CBI was coupled using DCC/NHS activation to give the corresponding polyamide-seco-
CBI conjugates 2R and 2S (Figure 2.7). The control seco-CBI analogues 3R and 3S with 
the same charge as the polyamide analogues were prepared by coupling the ()-alanine 
derivatives 5R and 5S to N,N-dimethyl-y-amino butyric acid. Purification by reverse 
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Figure 2.7. Synthetic scheme for preparation of seca-CBI-polyamide conjugates 2R and 2S. Polyamide 1 
was prepared by already disclosed methods. (i) Disuccinimidyl Glutarate, DMF, 2 H (ii) amine of SR or 
SS, DCC, NHS, DIEA, DMF, 3H. 
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Figure 2.8. Synthesis of unlinked control compound 3R. (i) 3M HCI!EtOAc, 30 min; (ii) 4-
Dimethylamino butyric acid, HBTU, DIEA, DMF. 
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277 bp Pv II 
RD-dqACqqqqCCAddCdd~ddA~qqqqqCCAddCddAAd~qqCCAddAdCqqddCdqAAqC~AdCq-P D 
3'-CATGAAAAGGTCCGCC CCTC AAAAAddqCCdCCqqC~ddqCCqCdAACCdCAqqAd~qCdA-RD 
Ma~ M~h 
Figure 2.9. Illustration of the 277 base pair EcoRI/Hindlll restriction fragment with the position of the 
sequence indicated. The binding sites for polyamide I , 5'-AGGACT-3' and 5'-TGGTCA-3' are boxed. A 
single base pair mismatch site is a lso boxed, the mismatch shaded. 
Thermally induced cleavage reactions 
To examine the alkylation specificity and reaction yields of the polyamide-seco-
CBI conjugates 2R and 28, thermally induced cleavage assays were performed on a 277 
base pair restriction fragment containing two match sites, 5' -AGGACT -3' and 5'-
TGGTCA-3' and one mismatch site, 5'-AGGAGT-3' (mismatch underlined), with 
different AfT tracts flanking the 3' side (Figure 2.9). Polyamide 2R at a concentration of 
500 pM alkylates a single adenine on the 3'-labeled (bottom) strand two base pairs to the 
3' side of the match site 5'-AGGACT-3' with a yield of74.5% (Figure 2.10b). At 200 
pM concentrations of polyamide 2R a second cleavage site appears on the same strand at 
a single adenine proximal to the mismatch site 5' -AGGAGT-3'. At 1nM concentrations 
of 2R and 12 hours of equilibration near quantitative cleavage (96%) of the intact DNA is 
observed (Figure 2. 10b). Remarkably, the reaction appears to be strand specific. No 
cleavage appears on the 5'-labeled (top) strand (Figure 2.10a). 
In constrast, polyamide 2S at 50 pM concentrations affords one major cleavage 
site on the 5' -labeled (top) strand corresponding to the adenine two base pairs to the 3' 
side of the polyamide match si te 5 '-TGGTCA-3 '. At 1 nM concentrations of2S cleavage 
yields of 42% are observed (Figure 2. 1 Oa). On the 3' labeled (bottom) strand, only minor 
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Figure 2.10. Thermally induced strand cleavage on the 5'-end labeled and 3'-end labeled 277 base pair 
restriction fragment by lmlmmymy-·fo·mo-CBg>_lmmymymy-~-ap (2R) and fmlmmymy-ys-um-CB g>_gmmymymy-~­
Dp (28). Storage phosphor autoradiograms of 8% denaturing polyacrylamide gels used to separate the 
fragments generated by heat induced DNA cleavage at alkylation sites. All lanes contain I 0 kcpm of either 
5' or 3' radiolabeled DNA. Each reaction was equilibrated in TE, pH 7.5 at 37 ·c for 12 H . The unbound 
polyamide was removed by precipitation, and then strand cleavage was induced by heating at 95 ·c for 30 
min. (a) 5'-32P-end labeled restriction fragment. (b) 3'-32P-end labeled restriction fragment. (a-b) lanes I 
and 14, intact DNA; lanes 2-1 I, 15-24 , I pM, 2 pM, 5 pM, I 0 pM, 20 pM, 50 pM, I 00 pM, 200 pM, 500 
pM, I nM respectively of the corresponding polyamide; lanes 12 and 25, A-specific reaction; lanes 13 and 
26, G-specific reaction. (a-b) Match sites 5'-TGGTCA-3' and 5'-AGGACT-3' and single base pair 
mismatch site 5'-AGGAQT-3' arc indicated in bold on the sequence, with arrows indicating cleavage bands. 
(a) 
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Figure 2.11. Time course experi ment of thermally induced strand cleavage on the 5'-end labeled and 3'-
end labe led 277 base pair restriction fragment by ImlmPyPy-·fR·uco-CBI>_ImPyPyPy-13-Dp (2R) and 
ImlmPyPy-ys-s.co-cs1>-ImPyPyPy-I3-Dp (2S). Storage phosphor autoradiograms of 8% denaturing 
polyacry lamide gels used to separate the fragments generated by heat induced DNA cleavage at alkylation 
sites. All lanes contain I 0 kcpm of either 5' or 3' radiolabeled DNA. Each reaction was equilibrated in 
TE, pH 7.5 at 37 ·c from 0 to I 0 hours. The unbound polyamide was removed by precipitation, and then 
strand cleavage was induced by heating at 95 ·c for 30 min. (a) 5'-32P-end labeled restriction fragment. (b) 
3'-32P-end labeled restriction fragment. (a-b) lanes I and II , intact DNA; lanes 2-8, I nM of corresponding 
polyamide, equilibrations for 0, 15 minutes, 30 minutes, I hour, 2 hours, 5 hours, and I 0 hours, 
respectively; lanes 9 and 19, A-specific reaction; lanes I 0 and 20, G-specific reaction. (a-b) Match sites 5'-
TGGTCA-3' and 5'-AGGACT-3' and single base pair mismatch site 5'-AGGAQT-3' are indicated in bold 
on the sequence, with arrows indicating cleavage bands. 
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alkylation and cleavage is observed at four sites in low yield (Figure 2.l0b). The two 
sites which can be assigned are proximal to a match 5'-AGGACT-3' and mismatch site 5'-
AGGAGT-3', respectively. 
Time Course Experiments 
To examine the time dependence of alkylation, reactions consisting of polyamides 
2R and 2S at 1 nM concentrations were analyzed throughout a period of I 0 hours. For 
the 5' -labeled strand, alkylation by 2S was first detected at 1 hour of incubation at 37 oc. 
After 10 hours, 24% of the DNA was cleaved proximal to the match site, 5'-TGGTCA-
3'. 2R shows no alkylation on this strand (Figure 2.11). However, 2R shows alkylation 
on the 3' -labeled strand after 15 minutes, and at 5 hours, has 76% yield proximal to the 
match site 5'-AGGACT-3', and 13% at the mismatch site 5'-AGGAGT-3' . After 10 
hours, 2S reveals minor cleavage products on the 3' -labeled strand, as described above 
for the titration experiments, each ranging from 1.5%-17% yield (Figure 2.11). 
Comparison of Conjugates to non-linked analogues 
In order to study the ability of polyamides to direct the reactivity of CBI 
analogues, alkylation by the unlinked analogues were analyzed as controls (Figure 2.12). 
Analogue 3R shows virtually no cleavage products at 1 J..LM concentrations, three orders 
of magnitude higher concentrations than that used in the conjugate studies. At 10 J..LM 
concentrations, 3R shows several cleavage products, but with yields only between 1.1 % 
and 5.1% on either strand. 3S is shown to be a more efficient alkylating agent than 3R. 
On the 5' -labeled strand, at 1 J..LM 3S, the majority of the cleavage products are at 1% 
yield or lower. On the 3' -labeled strand, the efficiency ranges from less than 1% to 7.7% 
at the same concentrations. At I 0 J..LM 3S, the experiments show quantitative cleavage of 
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the intact DNA for both strands, and the efficiency of alkylation on all sites increases 
accordingly. The yields range from 2%-25% and 2%-35% on the 3' and 5'-labeled 
strands, respectively. The consensus sequence for both enantiomers of CBI is an adenine 
for alkylation, a >95% preference for an A•T base pair to the 5' side of the adduct, and a 
66% preference for a purine to the 3' side. The alkylation pattern observed for both 3R 
and 3S shows that the AT tracts are particularly reactive sites, but the selectivity is 
difficult to predict (Figure 2.13). 
Discussion 
Strand Selective Cleavage 
One of the striking differences between polyamide-seco-CBI conjugates 2R and 
2S is the strand selectivity of alkylation shown by the respective diastereomers (Figure 
8). This is the result of combining the DNA binding properties of the polyamide and the 
opposite strand alkylation preference for each mirror image of CBI in the minor groove 
of DNA. The data supports a model wherein the hairpin polyamide binds both match and 
mismatch sites and directs the chiral CBI moiety to AfT tracts proximal to the bound 
sites. The electrophilic cyclopropyl carbon of the Rand S-CBI reacts at different rates 
with the N3 of adenine on opposite strands on the floor of the minor groove. The 
specificity of reaction at specific adenines represent the ratios of two unimolecular rate 
constants: the dissociation rate of the polyamide from the minor groove of DNA (koFF) 
and the alkylation rate of CBI at N3 of adenine in the minor groove of DNA (kALK). 
When the polyamide binds to a match site, koFF is expected to be slow relative to 
mismatch sites. Similarly, kALK will be faster for sites which accommodate the orientation 
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Figure 2.12. Thermally induced strand cleavage on the 5 ' -end labeled and 3 '-end labeled 277 base pair 
restriction fragment by lmlmmymy-yo·stco-csn_lmmymymy-~-ap (2R), lmlmmymy-ys-KIm-CB f F_ fmmymymy-~-ap 
(2S), EoF-seco-CBf-~-dimethy l-y (3R), EpF-seco-CBf-~-dimethy l -y (38). Storage phosphor autoradiograms 
of 8% denaturing polyacrylamide gels used to separate the fragments generated by heat induced DNA 
cleavage at alkylation sites. All lanes contain 10 kcpm of either 5 ' or 3' radiolabeled DNA. Each reaction 
was equilibrated in TE, pH 7.5 at 37 ·c for 12 H . The unbound polyamide or agent was removed by 
precipitation, and then strand cleavage was induced by heating at 95 ·c for 30 min. (a) 5'-32P-end labeled 
restriction fragment. (b) 3'-32P-end labeled restriction fragment. (a-b) Lane I, intact DNA; lane 2, 2R, 
lnM; Iane3 2S, lnM; Ianes 4-5, 3R, I !1M and 10 !1M, respectively; lanes6-7, 3S, 111M and 101-l-M, 
respectively; lane 8, A-specific reaction; lane 9, G-specific reaction. 
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Figure 2.13. Illustration of the 277 bp restriction fragment with the position of the sequence indicated. 
Cleavage patterns are shown for (a) ImlmPyPy-·r·mo-CBJ>_ymPyPyPy-13-Dp (2R), 500 pM; (b) ImlmPyPy-
y s-s.co-CBJ>_ImPyPyPy-13-Dp (2S), I nM; (c) (R)-seco-CB I-13-dimethyl-y (3R), I 0 J.l.M; and (d) (S)-seco-CBI-
13-dimethyl-y(3S), 10 11M. Match sites 5'-TGGTCA-3' and 5'-AGGACT-3' and single base pair mismatch 
site 5'-AGGAQT-3' are indicated in bold on the sequence, wi th arrows indicating c leavage bands. The 
single base pair mismatch is indicated by a rectangle. The polyamide is colored as in Figure 2.4b, with the 
bold triangle representing (R)-CBI. 
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and sequence preferences of CBI as in pure A!f tracts, and slower for mixed sequences. 
These ratios of koFF/kALK at different DNA sites give the variation in alkylation yields seen 
in these experiments. On the 5'-labeled (top) strand, polyamide 2S has one major 
cleavage site (Figure 2.10a and 2.lla) that is due to the polyamide binding the match site 
5'-TGGTCA-3' (slow koFF) and an adenine in the appropriate position proximal to the 
match site for alkylation (fast kALK). Likewise, on the 3'-labeled (bottom) strand, 
polyamide 2R has a major cleavage site (Figure 2.1 Ob and 2.11 b) due to the polyamide 
binding the match site 5'-AGGACT-3' (slow koFF) and an adenine on the opposite strand 
for alkylation (fast kALK). For the two DNA match sites bound by each diastereomeric 
polyamide-seco-CBI conjugate (2R and 28), koFF rates are expected to be similar. The 
variation in alkylation yields in these two instances most likely results from kALK being 
faster for the sequence proximal to the match site for 2R than for that of 2S. 
Similar comparisons can be made for alkylation seen at mismatch sites. On the 
3'-labeled (bottom) strand, polyamide 2R has a minor cleavage site (Figure 2.10b and 
2. 11 b) due to the polyamide binding the single base pair mismatch site 5'-AGGAGT -3' 
(fast koFF). But, because of favorable sequence contexts kALK is also fast. The alkylation 
at this site results from kALK being competitive with koFF• trapping that particular binding 
event. Also on the 3'-labeled (bottom) strand, polyamide 2S has two minor cleavage sites 
that can be assigned (Figure 2.10b and 2.11 b) . For the alkylation seen adjacent to the 
match site 5'-AGGACT-3', koFF is expected to be slow. In this case, kALK is also expected 
to be slow because the orientation preferences of S-seco-CBI are not optimal at this site. 
However, the binding event can be trapped because kALK may be competitive with koFF in 
this instance. 2S also affords an alkylation product next to the single base pair mismatch 
site 5'-AGGAGT-3'. While k oFF is expected to be faster in this case than for that of a 
match site, it can still be trapped for situations where k ALK is faster than koFF· 
41 
It has been shown for CC-1 065 and other analogues that the S, or ( + )-
enantiomers, are 10 times more reactive than the R, or (-)-enantiomers.4·19·20 The data 
shown for the control compounds 3R and 3S support this conclusion (Figure 2.12). It is 
interesting, then, that polyamide conjugate 2R shows higher alkylation efficiency and 
faster rates of alkylation than 2S. Work by Lukhtanov and coworkers have shown that 
when an oligonucleotide-cyclopropapyrroloindole conjugate is hybridized to a variety of 
complementary oligonucleotide hairpins, rates of reaction can be quite rapid, and yields 
can be quantitative.2 1 But the results are sequence dependent. In the case of the 
oligonucleotide conjugates, both enantiomers show fast and efficient alkylation in pure 
Aff tracts (t 112 as fast as 2 minutes), while mixed sequences seem to have slower and 
more unpredictable rates of reactivity. In our studies, the pure Aff tracts flanking the 
polyamide match sites differ and we may simply be observing sequence dependent 
differences in rates of reaction as a result of different adenine reactivities in various 
sequence contexts. 
Comparison with hairpin polyamide Duocarmycin A conjugates 
Previous work by Sugiyama and coworkers has established that Duocarmycin A 
(Duo), an analogue of CC-1065, will alkyl ate a guanine preferentially when bound as a 
heterodimer with distamycin.22 Sugiyama and coworkers have recently described 
pyrrole-imidazole hairpin polyamide conjugates which incorporate the natural enantiomer 
of Duo at the C-terminus.23 These molecules demonstrate the same altered reactivity at 
guanine, and target purines proximal to a hairpin polyamide binding site. Our choice of 
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using both enantiomers of seco-CBI was driven by the orientation preferences of CC-
1065 necessary for alkylation. These orientation preferences suggested that it might be 
possible to target either strand of the DNA duplex, based on the binding orientation of 
seco-CBI at that site. We have shown that the same hairpin polyamide can be used to 
target opposite strands of the DNA depending on the enantiomer of seco-CBI we choose. 
With the 6 ring hairpin polyamide-Duo conjugates, the highest yield Sugiyama and 
coworkers report is 7.4% cleavage at 800 nM polyamide for 7 days at room 
temperature.23 Despite the rather slow reaction kinetics, this compound shows very good 
specificity for its match site. No other cleavage sites are seen for this compound on the 
fragment analyzed. Our 8 ring hairpin polyamide-seco-CBI conjugate shows higher 
yields of alkylation at faster rates and lower concentrations of polyamide, 42% (at a 
single site) for 2S at 1 nM after 12 hours, and 74.5% (at a single site) for 2R at 500 pM 
after 12 hours, both at 3TC. But we do see contributions from mismatch alkylation sites, 
7.4% for 2R at 500 pM after 12 hours at 3TC. Because the two systems are very 
distinct, it is difficult to interpret the differences in the results. It is unclear how 
differences in hairpin polyamide (6 ring versus 8 ring), place of attachment (C-terminus 
versus turn), linker length (amide versus longer methylene), and alkylation conditions 
(time, temperature, ligand concentration, DNA concentration) will affect the overall 
reaction. It is worth noting that both sets of results show alkylation directed by hairpin 
polyamides in a sequence specific fashion . Differences in yields and rates of reaction can 




Hairpin polyamide-CBI conjugates have been shown to efficiently and selectively 
alkylate a single adenine adjacent to a polyamide match site. Because of the high 
efficiency of alkylation, these molecules should be useful in the design of reagents that 
target a single gene. It has already been shown that triplex forming oligonucleotide-
psoralen and nitrogen mustard conjugates form covalent adducts in the major groove on 
the coding strand to inhibit elongation of transcription.24 It remains to be seen whether 
this class of polyamide-CBI conjugates which react in the minor groove will be useful for 
functional genomics. 
Experimental 
Materials 1H NMR spectra were recorded on a General Electric-QE NMR spectrometer at 
300 MHz and a Varian Inova NMR spectrometer at 500 MHz with chemical shifts 
reported in parts per million relative to residual solvent. UV spectra were measured in 
water on a Hewlett-Packard Model 8452A diode array spectrophotometer. Optical 
rotations were recorded on a JASCO Dip 1000 digital polarimeter. Matrix-assisted, laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) was performed at 
the Protein and Peptide Microanalytical Facility at the California Institute of Technology. 
High resolution mass spectometry was performed at the mass spectrometry facility at 
University of California at Los Angeles. Preparatory reversed phase HPLC was 
performed on a Beckman HPLC with a Waters DeltaPak 25 x 100 mm, 300 A. Cl8 
column equipped with a guard, 0 .1% (wt/v) TFA, 0.25% acetonitrile/min. 
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Synthesis of CBI-polyamide conjugates 
lmlmmymy-EoF"zky-lmmymymy-~-ap (1). fmlmmymy-EoFeOky-fmmymymy-~-mam resin 
was synthesized in a stepwise fashion by Bee-chemistry manual solid phase protocols. 18 
A sample of resin was treated with neat (dimethylamino)-propylamine (2 ml), heated (55 
°C, 24 hours) and purified by reversed phase HPLC. ImlmPyPy-(R) eOky-fmmymymy-~-
Dp was recovered as a white powder upon lyophilization of the appropriate fraction ( 14.3 
I 
mg, 11.6 mmoles, 4.8% recovery). UV (H20) A.max (E), 312 nm, (66, 600); H NMR (500 
MHz, DMSO-d6): <>=11.009 (s, 1H), 10.325 (s, 1H), 10.073 (s, 1H), 9.947 (s, lH), 9.936 
(s, 1H), 9.870 (s, 1H), 9.07 (s, 1H), 9.23 (br s, 1H, CF3COOH), 8.334 (s, 3H), 8.173 (t, 
1H, 1=6 Hz), 8.040 (t, lH, 1=6 Hz), 8.012 (t, 1H, 1=6 Hz), 7.567 (s, 1H), 7.530 (s, 1H), 
7.457 (s, 1H), 7.270 (s, lH), 7.256 (s, 1H), 7.200 (s, 1H), 7.177 (s, 1H), 7.164 (s, 1H), 
7.155 (s, 1H), 7.142 (s, 1H), 7.071 (m, 2H), 6.964 (s, 1H), 6.876 (s, 1H), 4.002 (m, 6H), 
3.978 (s, 3H), 3.853 (s, 3H), 3.842 (s, 3H), 3.833 (s, 3H), 3.807 (s, 3H), 3.792 (s, 3H), 
3.375 (q, 2H, 1=5.5 Hz), 3.294 (m, 2H, 1=5.5 Hz), 3.106 (q, 2H, 1=6.5 Hz), 2.997 (m, 
3H), 2.735 (s, 3H), 2.725 (s, 3H), 2.343 (t, 2H, 1=7 Hz), 1.738 (m, 2H), 1.633 (m, 2H). 
MALDI-TOF-MS (monoisotopic) [M+H] 1238.83 (calculated 1238.58 for 
C57H72N230 1 0.) 
fmlmmymy-EoFc1u·kesy-fmmymymy-~-ap (1-DSG). To a solution of disuccinimidyl 
glutarate (41.9 mg, 120 !Jmoles) in 2.5 ml DMF was added 100 ml of a 14.3 mM solution 
of 1 (15.9 mg, 12.8 !Jmoles) in DMF (800 !Jl) and DIEA (100 !Jl). 100 ml of the solution 
was added every 15 minutes while stirring. Following the completion of the addition of 
1, the reaction was stirred for 2 hours. The reaction was diluted with 0.1% TFA ( 15 ml) 
and the reaction was purified by reversed phase HPLC. ImlmPyPy-(R)Giu-NHsy-
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fmmymymy-~-ap was recovered as a white powder upon lyophilization of the appropriate 
fraction (8.8 mg, 6.1 ~molesI 47.3% recovery). UV (H20) "-max(£), 312nm, (66, 600); 1H 
NMR (500 MHz, DMSO-d6 , 25°C): <3=10.320 (s, 1H), 10.242 (s, I H), 10.097 (s, 1H), 
9.930 (s, 2H), 9.872 (s, 1H), 9.740 (s, 1H), 9.23 (br s, IH, CF3COOH), 8.183 (d, lH, 1=8 
Hz), 8.034 (t, lH, 1=5.5 Hz), 8.010 (t, IH, 1=5.5 Hz), 7.946 (t, IH, 1=5.3 Hz), 7.563 (s, 
1H), 7.454 (s, lH), 7.272 (s, 1H), 7.263 (s, IH), 7.215 (s, 1H), 7.181 (s, 1H), 7.144 (m, 
4H), 7.080 (s, 1H), 7.061 (s, 1H), 6.887 (s, 1H), 6.870 (s, 1H), 4.001 (s, 6H), 3.957 (s, 
3H), 3.848 (s, 3H), 3.842 (s, 3H), 3.833 (s, 3H), 3.793 (s, 3H), 3.790 (s, 3H), 3.7-3.9 (br, 
m, 3H), 3.378 (q, 2H, 1=5.5 Hz), 3.228 (m, 2H), 3.107 (q, 2H, 1=6 Hz), 2.998 (m, 2H), 
2.741 (s, 3H), 2.731 (s, 3H), 2.345 (t, 2H, 1=7 Hz), 2.228 (m, 2H), 1.728 (m, 4H). 
MALDI-TOF-MS (monoisotopic) [M+H] 1449.63 (calculated 1449.62 for C66H81N240 15). 
fmlmmymy-EoF<o>·CBiy-fmmymymy-~-ap (2R). To a solution of 6 (6.9 mg, 4.75 ~molesF 
in dry DMF was added 47.5 ~f of a 1~M solution of DCC (10 equiv.) and 9.5 ~1 of a 0.5 
M solution of N-hydroxysuccinirnide ( 1 equiv.). The solution was stirred for 2 hours. 
Separately, a solution of SR (2 mg, 1 equiv.) was deprotected with 3M HCl/ethyl acetate 
(5 ml) for 30 minutes under argon. The ethyl acetate was then removed by vacuum and 
then coevaporated twice from dichloromethane to yield the amine of SR. The gray solid 
was then dissolved in 50 ml of dry DMF and then added to the polyamide solution. 
DIEA (8 ml, 10 equiv.) was then added and the reaction was stirred for 3 hours under 
argon. Upon completion, the reaction was diluted with 0.1 % TFA (2 ml) and the reaction 
was purified by reversed phase HPLC. fmlmmymy-Covo>-CBiy-fmmymymy-~-ap was 
recovered as a white powder upon lyophilization of the appropriate fraction ( 1.4 mg, 
17.8% recovery). UV (H20) "-max(£), 314 nm, (73, 854); 1H NMR (500 MHz, DMSO-d6, 
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25°C): ~=1MKP4O (s, 1H), 10.316 (s, 1H), 10.248 (s, lH), 10.096 (s, 1H), 9.928 (s, 2H), 
9.869 (s, 1 H), 9.691 (s, 1 H), 9.17 (br s, 1 H, CF3COOH), 8. 172 ( d, 1 H, 1=7 .5 Hz), 8.063 
(d, 1H, J=8Hz) 8.029 (t, 1H, 1=6 Hz), 8.008 (t, 1H, 1=5.5 Hz), 7.962 (m, 2H), 7.894 (t, 
1H, J= 5.5 Hz), 7.747 (d, 1H, 1=8 Hz), 7.556 (s, 1H), 7.464 (t, lH, 1=7.5 Hz), 7.449 (s, 
2H), 7.299 (t, 1H, J=7), 7.267 (s, 1H), 7.254 (s, 1H), 7.206 (s, 1H), 7.172 (s, 1H), 7.145 
(m, 3H), 7.059 (s, 2H), 6.892 (s, 1H), 6.870 (s, 1H), 4 .526 (q, 1H, 1=7 Hz), 4.287 (t, 1H, 
1=10.5 Hz), 4.111 (m, 2H), 3.998 (s, 6H), 3.948 (s, 3H), 3.844 (s, 3H), 3.837 (s, 3H), 
3.831 (s, 3H), 3.791 (s, 3H), 3.787 (s, 3H), 3.106 (q, 2H, 1=6.5 Hz), 3.004 (m, 4H), 
2.739 (s, 3H), 2.729 (s, 3H), 2.343 (t, 2H, 1=7.3 Hz), 2.181 (t, 2H, 1=7 Hz), 2.098 (t, 2H, 
1=7.8 Hz), 1.981 (m, 2H), 1.741 (m, 4H), 1.631 (m, 2H), 1.540 (m, 1H). MALDI-TOF-
MS (monoisotopic) [M+H] 1638.72 (calculated 1638.69 for C78H93N250 14). 
lmlmmymy-EovR>·CBiy-lmmymymy-~-ap (28). lmlmPyPy-(R)(S>-CB1g-lmPyPyPy-b-Dp 
was prepared from 6 as described for 2R. ( 1.4 mg, 30.4% recovery). UV (H20) Amax (E), 
314nm, (73, 854); 1H NMR (DMSO-d6): 1H NMR (500 MHz, DMSO-d6, 25°C): 
~=1MKP4P (s, 1H), 10.316 (s, 1H), 10.248 (s, 1H), 10.095 (s, 1H), 9.929 (s, 2H), 9.870 (s, 
1H), 9.689 (s, 1H), 9.19 (br s, 1H, CF3COOH), 8.173 (d, 1H, 1=7.5 Hz), 8.064 (d, 1H, 
1=8 Hz), 8.029 (m, 2H), d=7.963 (m, 2H, C4-H), 7.895 (t, 1H, 1=5.5 Hz), 7.747 (d, 1H, 
1=8 Hz), 7 .556 (s, 1H), 7.464 (t, 1H, 1=8 Hz), 7.451 (s, 1H), 7.445 (s, 1H), 7.299 (t, 1H, 
1=7.8 Hz), 7.266 (s, 1H), 7.255 (s, 1H), 7.206 (s, 1H), 7.175 (s, 1H), 7.145 (m, 3H), 
7.060 (s, 2H), 6.891 (s, 1H), 6.870 (s, 1H), 4.525 (q, 1H, 1=7 Hz), 4 .285 (t, 1H, 1=10.5 
Hz), 4.111 (d, 2H, 1=8.5 Hz), 3.998 (s, 6H), 3.951 (s, 3H), 3.844 (s, 3H), 3.837 (s, 3H), 
3.831 (s, 3H), 3.792 (s, 3H), 3.787 (s, 3H), 3.105 (q, 2H, 1=6 Hz), 3.000 (m, 4H), 2 .737 
(s, 3H), 2.729 (s, 3H), 2.343 (t, 2H, 1=6.8 Hz), 2.180 (t, 2H, 1=8 Hz), 2.099 (t, 2H, 1=8 
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Hz), 1.997 (m, 2H), 1.727 (m, 2H), 1.631 (m, 2H), 1.540 (m, 1H). MALDI-TOF-MS 
(monoisotopic) [M+H] 1638.71 (calculated 1638.69 for C78H93N250 1.J. 
3-(tert-Butoxycarbonyl)-1-( chloromethyl)-5-hydroxy-1,2-dihydro-3H -benz[ e ]indole 
(seco-CBI-BOC, 4) was synthesized and enantiomers separated by already published 
protoco1s.14- 16 
peco-CBf-~-alanine-BlC (SR and SS). 4 (85 mg, .255 mmoles) was deprotected in 3M 
HCI/ethyl acetate (10 rnl) for 30 minutes under argon. After the ethyl acetate was 
removed by evaporation, and the deprotected seco-CBI was coevaporated twice from 
dichloromethane. BOC-b-alanine (96.4 mg, 2 equiv.) and EDC (293.3 mg, 6 equiv.) 
were added with DMF (5 ml). The solution was stirred overnight under argon. After the 
reaction was complete, 15 ml of water was added, and the reaction was extracted 6 times 
with ethyl ether. The ether was washed with brine, and dried with Na2S04 , and purified 
by flash chromatography (5% methanolldichloromethane) to yield 5 as an off-white 
powder (90 mg, 86%). 
EoF-peca-CBf-~-alanine-BlC (SR): 1H NMR (300 MHz, CDCI3, 25.C): 0=9.37 (s, 1H), 
8.27 (m, 2H), 7 .62 (d, 1H, 1=8.1 Hz), 7.52 (t, 1H, 1=6.6 Hz), 7.38 (t, 1H, 1=7.5 Hz), 5.55 
(br t, I H), 4.19 (d, 1H, 1=10.2 Hz), 4.06 (t, I H, 1=9.9 Hz), 3.93 (m, 2H), 3.62 (m, 2H), 
3 .38 (t, 1H, 1=10.5 Hz), 2.75 (m, 2H), 1.44 (s, 9H); [a]29 0 = +25.8• (c=O.l); HRMS calcd. 
for C21 H25CIN20 4 : 404. 1503; found 404.1496. 
EpF-peca-CBf-~-alanine-BlC (SS): 1H NMR (300 MHz, CDCl3, 25"C): 0=9.37 (s, 1H), 
8.27 (m, 2H), 7.63 (d, lH, 1=8.1 Hz), 7.53 (t, 1H, 1=6.6 Hz), 7.40 (t, lH, 1=7.5 Hz), 5.55 
(br t, I H), 4 .21 (d, 1H, 1=10.2 Hz), 4.06 (t, 1H, 1=9.9 Hz), 3.96 (m, 2H), 3.64 (m, 2H), 
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3.40 (t, IH, 1=10.5 Hz), 2.75 (m, 2H), 1.44 (s, 9H); [af90 = -29.4• (c=0.1); HRMS calcd. 
for C2 1 H25CIN20 4 : 404.1503; found 404.1490. 
peco-CBf-~-alanine-EdimethylF-y-amino butyric acid (3R and 3S). 5 (5 mg, 12.3 
J..lmoles) was deprotected in 3M HCI/ethyl acetate (5 ml) for 30 minutes under argon. 
The ethyl acetate was removed by evaporation, and the deprotected seco-CBf-~-alanine 
was coevaporated twice from dichloromethane. Separately, a solution of (dimethyl)-y-
aminobutyric acid (4.1 mg, 2 equiv.) in DMF (200 J-11) was stirred in a flame dried flask 
with DCC (25.4 mg, 10 equiv) and N-hydroxysuccinimide (1.4 mg, 1 equiv.) for 1 hour 
under argon. This was added to the deprotected seco-CBf-~-alanine and OlEA (7 J-11, 3 
equiv.) was added. The solution was stirred for 1 hour under argon, and purified by 
reversed phase HPLC. peco-CBf-~-alanine-Edimethy1F-g-aminobutyric acid was 
recovered as a white powder upon lyophilization of the appropriate fraction. 
EoF-peco-CBf-~-alanine-EdimethylF-y-aminobutyric acid (3R): 2.5 mg, 48% (recovery) 
1H NMR (300 MHz, CD3CN, 25.C): 0=10.9 ( br s, 1H), 8.12 (d, 1H, 1=7.5 Hz), 8.02 (s, 
!H), 7.69 (d, 1H, 1=8.4 Hz), 7.48 (t, 1H, 1=8.4 Hz), 7.33 (t, IH, 1=6.9 Hz), 7.09 (br s, 
1H), 4.15 (m, 2H), 3.93 (d, 3H), 3.63 (t, 2H), 3.51 (m, 2H), 3.04 (m, 4H), 2.71 (s, 6H), 
HRMS calcd. for C22H29CIN30 3 (M+H): 418.1897; found 418.1889. 
(S)- peco-CBf-~-alanine-EdimethylF-y-aminobutyric acid (3S): 3.4 mg, 66% (recovery). 
1H NMR (300 MHz, CD3CN, 25.C): 0=10.9 ( br s, !H), 8.13 (d, I H, 1=8.1 Hz), 8.00 (s, 
1H), 7.74 (d, 1H, 1=8.4 Hz), 7.50 (t, 1H, 1=7.5 Hz), 7.34 (t, IH, 1=7.5 Hz), 7.00 (br s, 
1H), 4.23 (m, 2H), 4.20 (m, I H), 3.93 (d, 2H), 3.67 (t, 2H), 3.51 (m, 2H), 3.04 (t, 2H), 
2.75 (s, 6H). HRMS calcd. for C22H29CIN30 3 (M+H): 418.1897; found 418.1907. 
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DNA Reagents and Materials. Enzymes were purchased from Boehringer-Mannheim 
and used with their supplied buffers. Deoxyadenosine and thymidine 5' -[a-32P] 
triphosphates were obtained from Dupont/New England Nuclear, and deoxyadenosine 5'-
[y-32P] triphosphates were purchased from I.C.N. Sonicated, deproteinized calf thymus 
DNA was acquired from Pharmacia. RNase free water was obtained from USB and used 
for all reactions. All other reagents and materials were used as received. All DNA 
manipulations were performed according to standard protocols. 
Construction of Plasmid DNA. The plasmid pAC 1 was constructed using previously 
described methods. Fluorescent sequencing was performed at the DNA Sequencing 
Facility at the California Institute of Technology and was used to verify the presence of 
the desired insert. Concentration of the prepared plasmid was determined at 260 nm from 
the relationship of 1 OD unit=50 f..lg mL·' duplex DNA. 
PCR Labeling to generate 5'-End-Labeled Restriction Fragments. Two 21 mer 
primers were synthesized for PCR amplification: primer A (labeled)5'-
AATTCGAGCTCGGTACCCGGG-3' and primer B (unlabeled) 5'-
CTGGCACGACAGGTTTCCCGA-3'. Primer A was treated with T4 polynucleotide 
kinase and deoxyadenosine 5'-[y-32P] triphosphate as previously described. PCR 
reactions containing 60 pmol each primer, 10 f..ll PCR buffer (Boehringer-Mannheim), 3.7 
f..ll template (0.003 f..lg/mL) , 2 f..ll dNTP mix (each at 10 mM), 1 f..ll lOOX BSA (New 
England Biolabs) and 83 f..ll water were heated at 70 oc for 5 minutes. Four units of Taq 
Polymerase were added (Boehringer-Mannheim). Thirty amplification cycles were 
performed, each cycle consisting of the following segments: 94 OC for 1 minute, 54 OC 
for 1 minute, and 72 OC for 1.5 minutes. Following the last cycle, 10 minutes of 
extension at 72 ·c completed the reaction. The PCR products were gel purified as 
previously reported for 3' -end labeling protocols. 
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Cleavage Reactions. AJI reactions were carried out in a volume of 50 tJI. A polyamide 
or seca-CBI-dimethyl gaba stock solution or water (for reference lane) was added to an 
assay buffer of TE (pH7 .5) and 20 kcpm of 3'- or 5' -radiolabeled DNA. The solutions 
were aJJowed to equilibrate for 12 hours or the appropriate time (for time course 
reactions) at 37 ·c. The reactions were stopped with 60 tJl of a solution containing 
NaOAc (600 mM), EDTA pH 8.0 (12.5 mM), calf thymus DNA (150 J1M base pair), 
glycogen (0.8 mg rnL-1), and NaCl (2 M). Ethanol was added to remove unbound 
polyamide and precipitate the products. The reactions were resuspended in 20 fJI of TE 
(pH 7.5) and cleavage was initiated by heating at 95 ·c for 30 minutes. The cleavage 
products were precipitated with 150 tJI ethanol and then resuspended in 100 mM 
trisborate-EDT A/80% formamide loading buffer, and denatured and loaded onto 
polyacrylamide gels as previously reported. The gels were quantitated by the use of 
storage phosphor technology. Yield or efficiency of a lkylation was determined as the 
ratio between the volume integration assigned to the products and the sum of the volumes 
of aJJ the products in the Jane. 
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CHAPTER THREE 




Pyrrole-Imidazole (Py-lm) polyamides are cell permeable ligands that can be 
targeted to any predetermined DNA sequence. Py-Im polyamide-seco-CBI conjugates 
are capable of cleaving DNA in high yields at targeted adenines proximal to the 
polyamide binding site. Because of the generality of the pairing rules, and polyamides 
demonstrated utility in in vivo systems, these conjugates may be useful for studying the 
effects of this class of DNA binding ligands on homologous recombination and DNA 
repair. Triplex oligonucleotides have previously been shown to influence homologous 
recombination and directed mutagenesis. The effects of other DNA binding ligands on 
these processes have not been established. Described are the design and synthesis of Py-
Im polyamide-seco-CBI conjugates that cleave DNA at a determined site on a specific 
gene. Currently, these compounds are being studied in vivo in hopes that DNA cleavage 
will stimulate a DNA repair event and homologous recombination. If successful, these 
studies could have future applications in the areas of gene therapy. 
Background 
Using DNA-binding Ligands to Study DNA Repair Processes 
Synthetic ligands that can target specific sequences of DNA and bind with high 
affinity are currently studied to manipulate transcription in both in vitro and in vivo 
systems. Previously were described efforts to inhibit or activate transcription by using 
Py-Im polyamides to compete with the binding of required transcription factorsK~KO Other 
endeavors in this regard involve using such ligands to interfere with transcription 
elongation through covalent attachment to the DNA via a reactive moiety linked to the 
DNA-binding ligand. This approach was discussed concerning Py-Im polyamides 
conjugates with seco-CBI.' 
57 
Another use for the study of molecules that target specific sequences of DNA is in 
the area of gene repair. Researchers often use DNA damaging agents to study how cells 
repair such damage, and how efficient and accurate these repair processes are. One 
problem with the majority of DNA damaging agents is that they have broad sequence 
selectivities, making it difficult to study the effects on a specific gene. There is much 
interest in being able to target a specific gene and study how the cell can repair such 
damage, and if that repair is accurate.4 While the majority of the time accurate repair of 
DNA damage is desirable, there may be instances where an error in DNA repair can yield 
a beneficial result. This idea of directed mutagenesis is one approach to gene therapy. If 
it were possible that a gene specific ligand could induce a favorable mutation during the 
repair process, then the genome of that cell would be permanently altered for the better. 
Understanding the processes that guide and direct DNA repair will ultimately have 
implications in this discipline. 
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Much of the research in using DNA-binding ligands to study DNA repair 
processes has used triplex oligonucleotides.5·6 There are well established rules of triplex 
formation and their recognition sequences, and they are easily synthesized and accessible. 
However, triplex oligonucleotides face problems in delivery because they are anionic 
polymers, and in stability because they are subject to degradation by nucleases. The 
recognition sequences are often restricted to purine tracts which limit their use in any 
given gene. The merits of using Py-Im polyamides to study DNA repair are evident in 
the generality of the pairing rules7, their cell permeabilityi.8, and accessibility through 
solid phase synthesis.9 
To study DNA repair and recombination, we proposed using Py-Im polyamides to 
direct known DNA damaging agents to specific genes. The Jack of sequence specificity 
in traditional DNA alkylating agents such as nitrogen mustards, CC-1065, and mitomycin 
make them unsuitable for a gene specific study of DNA repair. The use of polyamide 
conjugates allows us to control the damage inflicted in order to stimulate repair and 
recombination to the particular gene in study. In collaboration with Dr. Matt Porteus of 
the Baltimore group, experiments were designed to use polyamide conjugates of seco-
CBI, nitrogen mustards (Mr. Nicholas Wurtz of the Dervan group), and camptothecin 
(Mr. Clay Wang of the Dervan group) to stimulate DNA repair and homologous 
recombination. Described here are the efforts in using seco-CBI polyamide conjugates 
for these experiments. 
Experimental Design 
The experimental design was based on observations in the Baltimore group using 
Green Fluorescent Protein (GFP). When a mutant GFP gene with an internal stop codon 
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is expressed, functional GFP is not detected (Figure 3.la). When substrate DNA is added 
containing the wild type gene is added, homologous recombination occurs such that 
functional GFP can be detected for 1 in every 106 cells (Figure 3. lb). If instead of the 
internal stop codon, a site for a rare-cutting restriction enzyme is inserted4, a double 
strand break can be generated. For the case of homologous recombination with the 
substrate for the double strand break, functional GFP can be detected for 1 in every 500 
cells (Figure 3.1c). Thus these experiments were designed to address the question of 
whether or not polyarnides could be used to incorporate a double strand break, and if so 
could we generate similar results of recombination and mutagenesis (Figure 3.ld). 
STOP 
(a) Mutant GFP 
with internal Stop 
No GFP Expression 
(b) Mutant GFP STOP 
with internal Stop 
+ 
Wild Type 1 in 10
6 show GFP Expression 
Substrate 
(c) Mutant GFP with Restriction Site 
Restriction Site yielding 




Wild Type 1 in 500 show GFP Expression 
Substrate 
(d) Mutant GFP with Polyamide Binding Site Polyamide Binding Site 
yielding double strand break 
! ~ 
c=J 
Wild Type + ·················~ GFP Expression??? 
Substrate 
Figure 3.1. Experimental design for proposed polyamide conjugates. See text for further details. 
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Nick Wurtz of the Dervan group chose three polyamides to examine in these 
experiments (Figure 3.2). Two constructs were designed to incorporate these 
polyamides. The first uses the two hairpin dimers fmmy-~-fmmy-yo>·CU1-my-~-fmimmy-~­
Dp (lR) and fmim-~-fmlm-y-<o>-CBg_mymy-~-mymy-~-ap (2R ). The second uses the 
homodimer fmlmmymy-~-mymymymy-~-qA-EpF-CBf (3S). The polyamides selected have 
have been previously characterized and have high binding affinities and good 
specificities to mismatch.1•10 The enantiomer of CBI chosen was determined by the insert 
design. Earlier studies showed that the strand selectivity of polyamide-seco-CBI 
conjugates is dependent on the enantiomer chosen. For the dimer insert, polyamides 1 
and 2 are designed in a 5' to 3' orientation from the alkylation site. Thus, for these 
polyamides, the (R)-enantiomer of CBI was chosen. This orientation is consistent with 
that of the parent alkylating agent and as well as with the previous studies of polyamide-
seco-CBI conjugates. For the homodimer insert, each half of the homodimer needs to 
bind in a 3' to 5' orientation from the alkylation site, thus dictating the need for the (S)-
enantiomer of seco-CBI. 
The insert containing the binding sites of the polyamides for each construct 
(dimer and homodimer) was inserted in the middle of the GFP gene (Figure 3.3). The 
insert includes a stop codon so that cells that do not undergo recombination will not 
express functional GFP. In the event of a double strand break, repair processes could 
correct the mutation, which would then be detectable by fluorescence. If the polyamides 
alkylate as designed to do, they will in theory act the same way as a rare-cutting 
endonuclease would, causing a double strand break. It is unclear what the effect of the 




Figure 3.2. Structures of the polyamide conjugates used for this study. ImPy-P-ImPy-·fR>-CBI_py-P-
ImlmPy-P-Dp (lR), Imlm-P-Imlm-y-1R>-ce1-PyPy-p-PyPy-p-Dp (2R), and ImlmPyPy-p-PyPyPyPy-p-TA-
(S)-CBI (3S). 
endoncleases typically either leave a blunt end or a 2 to 4 base overhang to either the 3' 
or 5' side. In the case of the dimers, the designed overhang will be similar to that of an 
endonuclease. In the case of the homodimers, there is a fairly substantial gap between 
the two cleavage sites of duplex DNA (19 bases). If there are differences observed 
between the two systems, a next generation design might try to incorporate a range of 
overhangs to see if a trend can be established. 
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GFP (1-327) GFP (328-720) 
Insert 
Dimer Insert: 
5 I -A T T A G c c G T A T T T A A A A c c A c c T A A T-3 I 
~~
3 1 -T A A T C G G CAT A A AT T T T G G T G GATT A-5 1 
1R 2R 
Homodimer Insert: 
5 1 -T T T T T AG G TAT T A C C T A A A A A-3 1 
KKKKao-<>-oo-oo<+>~----K 
·. __ K~E+F-<>-MMMM-<>-MM-
3 I -A A A A A T c c A T A A T G G A T T T T T-5 I 
3S 
Figure 3.3. DNA construct of dimer and homodimer inserts for GFP experiments. 
Results 
Synthesis of Polyamide seco-CBI-Conjugates 
The parent unmodified polyamides 1, 2, and 3 were synthesized on solid support 
as previously reported.9 Polyamides 1 and 2 were synthesized with (R)-2,4-
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diaminobutyric acid (DABA) in the tum position.'' A succinimidyl ester was attached to 
the amine of the tum to yield 1-DSG. Subsequent addition of (R)-1)-ala-seco-CBI yielded 
the desired polyamide-seco-CBI conjugate.3 A representative conjugate synthesis is 
shown in Figure 3.4. Polyamide 3 was cleaved from the resin with 3,3' -diamino-N-
methyldipropylamine (triarnine, T A) and the conjugates were then synthesized as 
polyamides 1R and 2R with the (S)-enantiomer of seco-CBI. 12 
Thermally Induced Cleavage Reactions 
Polyamide 1R was analyzed on a 221 base pair fragment of GFP containing the 
designed insert (Figure 3.5a). Analysis of the cleavage reactions reveal that polyamide 
1R aJkylates strongly at the adenine two base pairs removed from the designed match 
1-DSG 
Figure 3.4. Synthesis o f Polyamide-seco-CBI conjugates. ( i) DSG ( I 0 equiv .), ( ii) EoF-seco-CBf-~-a l aK 


















Figure 3.5. GFP fragments used in this study. Insert with polyamide binding sites are between the dashes, 
polyamide binding sites are in bold. (a) dimer construct, (b) homodimcr construct. 
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site, 5 '-AGCCGTA-3' on the bottom strand (Figure 3.6b). At 1 nM concentrations, lR 
cleaves this match site with a yield of 79%. On this strand, excellent specificity is 
shown, as 2 mismatch alkylation sites only begin to appear at 10 nM concentrations. 
These sites correspond to a double base pair mismatch 5' -CGCCGAG-3' (mismatch 
underlined) and a second double base pair mismatch 5' -AGGTGAA-3'which have 
cleavage yields of 13% and 9% respectively at 10 nM concentrations. The opposite 
strand (top strand) of this fragment was also examined to determine if there were 
mismatch alkylation sites on this strand as well (Figure 3.6a). On this strand, polyamide 
lR shows one strong alkylation site at a single base pair mismatch site 5'-TGCCGTC-3' . 
The yield of alkylation at this site is 79% at 3 nM concentrations of polyamide lR. 
Polyamide 2R was examined on the same 221 base pair fragment as polyamide 
lR (Figure 3.5a). On the top strand proximal to the intended match site 5' -AGGTGGT-
3', polyamide 2R shows a strong alkylation site which starts to appear at 30 pM (Figure 
3.7a). At 1 nM concentrations polyamide 2R, the cleavage yield is 86% at this site. On 
the same strand at 3 nM concentrations, alkylation is observed proximal to a double base 
pair mismatch site 5' -AGGTCTT -3' . The cleavage yield at this site is 19% at 3 nM and 
56% at 10 nM concentrations. On the bottom strand, one alkylation site is seen at a single 
base pair mismatch site 5' -AGGTGAA-3'(Figure 3.7b). The alkylation band appears at 3 
nM concentrations and cleaves with 75% yield at 10 nM concentrations. 
Polyamide 3S was assayed on a 215 base pair fragment containing the homodimer 
polyamide match site (Figure 3.5b). Both strands show alkylation at the designed match 
site 5'-AGGTATTACCT-3'. For both strands, alkylation is seen starting at 300 pM 
(Figure 3.8). The top strand alkylation seems more spec ific, which has a cleavage yield 
Figure 3.6. Thermally induced strand cleavage on the 5'-end labeled and 3'-end labeled 221 base pair 
restriction fragment by ImPy-P-ImPy-yR-mo-CBI>_py-P-ImlmPy-P-Dp (lR). Storage phosphor 
autoradiograms of 8% denaturing polyacrylamide gels used to separate the fragments generated by heat 
induced DNA cleavage at alkylation sites. All lanes contain I 0 kcpm of either 5' radio labeled DNA. Each 
reaction was equilibrated in TE, pH 7.5 at 37 ·c for 12 H. The unbound polyamide was removed by 
precipitation, and then strand cleavage was induced by heating at 95 ·c for 30 min. (a) 5"-32P-end labeled 
restriction fragment-top strand. (b) 5'-32P-end labeled restriction fragment-bottom strand. (a-b) lane I, 
intact DNA; lanes 2-8, I 0 pM, 30 pM, I 00 pM, 300 pM, I nM, 3 nM, I 0 nM respectively of the 
corresponding polyamide; lane 9, A-specific reaction; lane 10, G-specific reaction. (a-b) Match site 5'-
AGCCGTA-3' and single base pair mismatch site 5'-QACGGCA-3' are indicated in bold on the sequence, 
with arrows indicating cleavage bands. 
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1 R: lmmy-~-lmmy-yoF-cs1 - my-~-lmlmmy-~-ap 
(a) 
Top Strand 





































































Figure 3.7 Thermally induced strand cleavage on the 5'-end labeled and 3'-end labeled 221 base pair 
restriction fragment by lmlm-~-fmlm-Dfo·mo-cBf>_pymy-~-mymy-~-ap (2R). Storage phosphor 
autoradiograms of 8% denaturing polyacrylamide gels used to separate the fragments generated by heat 
induced DNA cleavage at alkylation sites. All lanes contain I 0 kcpm of either 5' radio labeled DNA. Each 
reaction was equilibrated in TE, pH 7.5 at 37 ·c for 12 H. The unbound polyamide was removed by 
precipitation, and then strand cleavage was induced by heating at 95 ·c for 30 min. (a) 5'-32P-end labeled 
restriction fragment-top strand. (b) 5'-32P-end labeled restriction fragment-bottom strand. (a-b) lane I , 
intact DNA; lanes 2-8, I 0 pM, 30 pM, I 00 pM, 300 pM, I nM, 3 nM, I 0 nM respectively of the 
corresponding polyamide; lane 9, A-specific reaction; lane I 0, G-specific reaction. (a-b) Match site 5'-
AGGTGGT-3' and single base pair mismatch site 5'-AGGTcrT-3' and 5'-AGGTGAA-3' are indicated in 











































































Figure 3.8 Thermally induced strand cleavage on the 5' -end labeled and 3' -end labeled 215 base pair 
restriction fragment by ImlmPyPy-p-PyPyPyPy-P-TA-(S)-CBI (38). Storage phosphor autoradiograms of 
8% denaturing polyacrylamide gels used to separate the fragments generated by heat induced DNA 
cleavage at alkylation sites. All lanes contain I 0 kcpm of either 5' radiolabeled DNA. Each reaction was 
equilibrated in TE, pH 7.5 at 37 ·c for 12 H. The unbound polyamide was removed by precipitation, and 
then strand cleavage was induced by heating at 95 ·c for 30 min. (a) 5'-32P-end labeled restriction 
fragment-top strand. (b) 5'-32P-end labeled restriction fragment-bottom strand. (a-b) lane I, A-specific 
reaction; lane 2, G-specific reaction; lane 3, intact DNA lanes 4-10, I 0 pM, 30 pM, I 00 pM, 300 pM, I 
nM, 3 nM, I 0 nM respectively of the corresponding polyamide. (a-b) Match site 5'-AGGTA TTT ACCT-3' 
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of69% at the target site at 10 nM concentrations of polyamide 3S (Figure 3.8a). There 
are other alkylation bands on this strand, none of which account for more than 5% of the 
total DNA in the lane. Alkylation on the bottom strand was seen at a lower yield, 30% 
yield at the match site at 10 nM concentrations of polyamide 3S (Figure 3.8b). Other 
mismatch alkylation sites show yields as high as 10%-15% at the same concentrations. 
Polyamide 3S was not as soluble as the hairpin polyamides lR and 2R, which may 
account for the higher concentrations needed to observe alkylation. 
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A summary of the alkylation sites for the dimer and homodimer sites are 
illustrated in Figure 3.9. At 1 nM concentrations of each of the hairpin polyamides lR 
and 2R, the majority of cleavage sites are in the designed region. The use of these two 
polyamides together should afford a double strand break with a three base pair overhang. 
There is also a large contribution from single base pair mismatch alkylation site for lR. 
It is unclear how this alkylation site will affect the in vivo assays. The homodimer 3S 
alkylates fairly specifically at 3 nM concentrations, but at lower yields than the hairpin 
polyamide conjugates. It will be interesting to compare the results of these two systems 
to determine the effects, if any, of the in vitro yields versus in vivo result, issues of 
solubility and permeability, and the nature of the double strand break (a few base 
overhang versus >15 bases). 
Gene Correction Experiments 
Currently, Dr. Matt Porteus of the Baltimore group is working to set up these 
experiments to study the effects of Py-Im polyamides on homologous recombination. It 
was hoped that upon treatment with polyamide-alkylator conjugates, cells that had 
undergone recombination or repair would be detected by expression of GFP. The results 
of these experiments thus far have shown that the polyamide-seco-CBI conjugates were 
toxic to cells at 500 nM and 1 !J.M concentrations. When the levels of RNA production 
are measured, the global levels of RNA are reduced and no gene specific reduction in 
RNA synthesis is observed. 
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In order to further study these phenomena, Dr. Porteus has designed a second 
assay to examine the repair of the DNA damage inflicted by polyamide-alkylator 
conjugates. His second assay uses a p-galactosidase (lacZ) system (Figure 3.10). The 
lacZ gene with an internal frameshift is not catalytically active and thus will not show 
color change upon treatment with X-gal and IPTG. Just by the cellular repair machinery 
alone (without added wild type substrate and recombination events), 1 in every 5000 cells 
will change color, indicating that repair has restored the activity of lacZ. If the 
polyamide-conjugate binding site is placed at the site of the frameshift, upon repair of the 
lesion formed by the polyamide-seco-CBI conjugate, a certain number of the cells should 
show restored lacZ activity. The first experiments will use plasmid DNA incubated with 
polyamide conjugate. The plasmid DNA is then transfected into cells and the cell's own 
repair machinery will repair the lesions, restoring lacZ activity. If these plasmid DNA 
experiments are successful, Dr. Porteus will incorporate the lacZ gene with polyamide 
binding sites into the genomic DNA of the cells, and repeat the previous plasmid 
experiments. The increased sensitivity of this assay to repair will be useful for 




















































































































































































































































































































































































































(a) Mutant lacZ with 
internal frame shift 
(b) Mutant lacZ with 
Polyamide Binding Site 
yielding double strand break 
frame shift 
Polyamide Binding Site 
Cellular 
DNA repair 
1 in 5000 have 
functional lacZ 
and turn blue 
lacZ Expression??? 
Figure 3.10. LacZ experiments for detecting DNA repair by polyamide-seco-CBI conjugate damaged 
DNA. See text for further details. 
Conclusions 
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The design of Py-Im polyamide conjugates with seco-CBI incorporates the ability 
to target specific DNA sequences and cause a covalent reaction on the DNA in a 
sequence specific fashion. We believe that this class of molecules, in concert with other 
polyamide conjugates with nitrogen mustards1\ camptothecin, mitomycin, and PNAs, 
will provide powerful tools for studying and manipulating transcription in the cell. The 
results of the forthcoming in vivo experiments, whether positive or negative, will shape 
the design of additional motifs for these classes of compounds and point to new 
directions to apply these molecules to. 
Experimental 
Materials 
1H NMR spectra were recorded on a General Electric-QE NMR spectrometer at 300 MHz 
and a Varian Inova NMR spectrometer at 500 MHz with chemical shifts reported in parts 
per million relative to residual solvent. UV spectra were measured in water on a Hewlett-
Packard Model 8452A diode array spectrophotometer. Matrix-assisted, laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) was performed at 
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the Protein and Peptide Microanalytical Facility at the California Institute of Technology. 
Preparatory reversed phase HPLC was performed on a Beckman HPLC with a Waters 
DeltaPak 25 x 100 mm, 300 A C18 column equipped with a guard, 0.1% (wt/v) TFA, 
0.25% acetonitrile/min. 
Synthesis of CBI-polyamide conjugates 
lmmy-~-fmmy-EoF"Oky-my-~-lmlmmy-~-ap (1). fmmy-~-fmmy-EoF"Oky-my-~-frnlmmy-~-
Pam resin was synthesized in a stepwise fashion by Boc-chemistry manual solid phase 
protocols. A sample of resin was treated with neat (dimethylarnino)-propylamine (2 ml), 
heated (55 °C, 24 hours) and purified by reversed phase HPLC. fmmy-~-fmmy-EoF"Oky­
my-~-fmlmmy-~-ap was recovered as a white powder upon lyophilization of the 
appropriate fraction ( 14.4 mg, 10.4 1-lmoles, 6.8% recovery). UV (H20) Amax (£), 312 nm, 
(66, 600); MALDI-TOF-MS (monoisotopic) [M+H] 1381.70 (calculated 1380.64 for 
C62HsoN260,2)· 
fmmy-~-fmmy-EoFcDu-kesy-my-~-fmlmmy-~-ap (1-DSG). To a solution of disuccinimidyl 
glutarate (41.9 mg, 120 fJIDOles) in 2.5 ml DMF was added 100 I-ll of a 14.3 mM solution 
of 1 (15.9 mg, 12.8 11moles) in DMF (800 f.ll) and DIEA ( 100 fJl). 100 I-ll of the solution 
was added every 15 minutes while stirring. Following the completion of the addition of 
1, the reaction was stirred for 2 hours. The reaction was diluted with 0.1% TFA ( 15 ml) 
and the reaction was purified by Sep Pak C 18• frnmy-~-fmmy-EoFdDu -kesy-my-~-fmlmmy-~-
Dp was recovered as a white powder upon lyophilization of the appropriate fraction. UV 
(H20) Amax (£), 312nm, (66, 600). 
lmmy-~-lmmy-EoF<o>-cu 1y-my-~-lmlmmy-~-ap (1R). To a solution of 1-DSG (1.8 mg, 
1.12 fJmoles) in dry DMA was added 30 111 of a 1f.1M solution of DCC (10 equiv.) in 
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DMA and 6111 of a 0.5 M solution of N-hydroxysuccinimide ( 1 equiv.) in DMA. The 
solution was stirred for 2 hours. Separately, a solution of seco-CBI-Boc-P-ala (0.45 mg, 
1 equiv.) was deprotected with 3M HCI/ethyl acetate (5 ml) for 30 minutes under argon. 
The ethyl acetate was then removed by vacuum and then coevaporated twice from 
dichloromethane to yield seco-CBI-P-ala amine. The gray solid was then dissolved in 50 
J.ll of dry DMF and then added to the polyamide solution. DIEA (2 J.ll , 10 equiv.) was 
then added and the reaction was stirred for 3 hours under argon. Upon completion, the 
reaction was diluted with 0.1 % TFA (2 ml) and the reaction was purified by reversed 
phase HPLC. ImPy-P-ImPy-(R)<R>·CBJy-Py-P-ImlmPy-P-Dp was recovered as a white 
powder upon lyophilization of the appropriate fraction (0.6 mg, 337 nM, 30% recovery). 
UV (H20) A.max (E), 314 nm, (73, 854); MALDI-TOF-MS (monoisotopic) [M+H] 1781.9 
(calculated 1780.76 for C83H 101 CIN280 16). 
Imlm-P-Imlm-(Rt2Ny-PyPy-p-PyPy-p-Dp (2). Imim-P-Imim-(R)H2Ny-PyPy-p-PyPy-p-
Pam resin was synthesized in a stepwise fashion by Soc-chemistry manual solid phase 
protocols. A sample of resin was treated with neat (dimethylamino)-propylamine (2 m1), 
heated (55 °C, 24 hours) and purified by reversed phase HPLC. Imlm-P-Imlm-(Rt2Ny-
PyPy-P-PyPy-p-Dp was recovered as a white powder upon lyophilization of the 
appropriate fraction (12.9 mg, 9.3 J.lmoles, 12.1% recovery). UV (H20) A.max (£), 312 nm, 
(66, 600); MALDI-TOF-MS (monoisotopic) [M+H] 1381.76 (calculated 1380.64 for 
C62HsoN26012). 
lmlm-P-Imlm-(R)c1u·NHsy-PyPy-p-PyPy-p-Dp (2-DSG). 2-DSG was prepared in an 
analogous fashion to 1-DSG from 2. Imlm-P-Imlm-(R)G1u·NHsy-PyPy-p-PyPy-p-Dp was 
recovered as a white powder upon lyophilization of the appropriate fraction. UV (H20) 
A 111ax (£), 312nm, (66, 600). 
fmlm-~-fmlm-EoF<o>·cu•y-mymy-~-mymy-~-ap (2R). 2R was prepared in an analogous 
fashion to lR from 2-DSG. fmlm-~-fmlm-EoF<o>-CBiy-mymy-~-mymy-~-ap was recovered 
as a white powder upon lyophilization of the appropriate fraction (0.8 mg, 457 nmoles, 
12.3 % recovery). UV (H20) A.max (£), 312nm, (73, 854); MALDI-TOF-MS 
(monoisotopic) [M+H] 1781.73 (calculated 1780.76 for C83H 101 ClN280 16). 
fmlmmymy-~-mymymymy-~-TA (3). fmlmmymy-~-mymymymy-~-mam resin was 
synthesized in a stepwise fashion by Bee-chemistry manual solid phase protocols. A 
sample of resin was treated with neat 3,3'-diamino-N-methyldipropylamine (triamine-
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T A) (2 ml), heated (55 °C, 24 hours) and purified by reversed phase HPLC. IrnlmPyPy-
~-mymymymy-~-qA was recovered as a white powder upon lyophilization of the 
appropriate fraction (14.2 mg, 11.4 J..lmoles, 14.8% recovery). UV (H20) ~ •• (E), 312 nm, 
(66, 600) ; MALDI-TOF-MS (monoisotopic) [M+H] 1251.68 (calculated 1250.60 for 
C59H74N2201o). 
fmlmmymy-~-mymymymy-~-qA-diu-kep (3-DSG). 3-DSG was prepared in an 
analogous fashion to 1-DSG from z. fmlmmymy-~-mymymymy-~-qA-dlu-kep was 
recovered as a white powder upon lyophilization of the appropriate fraction. UV (H20) 
Amax (E), 312nm, (66, 600). 
fmlmmymy-~-mymymymy-~-qA-EpF-CBf (38). 3S was prepared in an analogous fashion 
to lR from 3-DSG and EpF-seca-CBf-~-alaK fmlmmymy-~-mymymymy-~-TA-(S)-CBI was 
recovered as a white powder upon lyophilization of the appropriate fraction (0.74 mg, 
446 nmoles, 9.4% recovery). UV (H20) A.rnax (E) , 312nm, (73 , 854); MALDI-TOF-MS 
(monoisotopic) [M+H] 1651.79 (calculated 1650.71 for C80H95ClN240 14). 
DNA Reagents and Materials. Enzymes were purchased from Boehringer-Mannheim 
and used with their supplied buffers. Deoxyadenosine 5' -[y-32P] triphosphates were 
purchased from I.C.N. Sonicated, deproteinized calf thymus DNA was acquired from 
Pharmacia. RNase free water was obtained from USB and used for all reactions. All 
other reagents and materials were used as received. All DNA manipulations were 
performed according to standard protocols. 
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Construction of Plasmid DNA. The plasmids GFP I and GFP2 were constructed by Dr. 
Matt Porteus. Concentration of the prepared plasmid was determined at 260 nm from the 
relationship of 1 OD unit=50 1-1g rnL-1 duplex DNA. 
PCR Labeling to generate 5'-End-Labeled Restriction Fragments. Two 21 mer 
primers were synthesized for PCR amplification: primer A (top)S'-AAG-CAG-CAC-
GAC-TTC-TTC-AAG-3' and primer B (bottom) 5'-CAG-GAT-GTT-GCC-GTC-CTC-
CTT-3' . To label the top strand, primer A was treated with T4 polynucleotide kinase and 
deoxyadenosine 5 ' -[y-32P] triphosphate as previously described. PCR reactions 
containing 60 pmol each primer, 10 f-11 PCR buffer (Boehringer-Mannheim), 3.7 f-11 
template (0.003 f..lg/rnL), 2 1-11 dNTP mix (each at 10 mM), 1 f-11 lOOX BSA (New England 
Biolabs) and 83 f-11 water were heated at 70 oc for 5 minutes. Four units of Taq 
Polymerase were added (Boehringer-Mannheim). Thirty amplification cycles were 
performed, each cycle consisting of the following segments: 94 OC for 1 minute, 54 OC 
for I minute, and 72 OC for 1.5 minutes. Following the last cycle, I 0 minutes of 
extension at 72 OC completed the reaction. The PCR products were gel purified as 
previously reported for 3 '-end labeling protocols. To label the bottom strand, primer B 
was labeled. 
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Cleavage Reactions. All reactions were carried out in a volume of 50 111. A polyamide 
stock solution or water (for reference lane) was added to an assay buffer ofTE (pH7.5) 
and 20 kcpm of 3'- or 5' -radiolabeled DNA. The solutions were allowed to equilibrate 
for 12 hours or the appropriate time (for time course reactions) at 37 oc. The reactions 
were stopped with 60 111 of a solution containing NaOAc (600 mM), EDTA pH 8.0 (12.5 
mM), calf thymus DNA (150 11M base pair), glycogen (0.8 mg mL. 1), and NaCl (2M). 
Ethanol was added to remove unbound polyamide and precipitate the products. The 
reactions were resuspended in 20 111 of TE (pH 7 .5) and cleavage was initiated by heating 
at 95 oc for 30 minutes. The cleavage products were precipitated with 150 fll ethanol and 
then resuspended in 100 mM trisborate-EDT N80% formamide loading buffer, and 
denatured and loaded onto polyacrylamide gels as previously reported. The gels were 
quantitated by the use of storage phosphor technology. Yield or efficiency of alkylation 
was determined as the ratio between the volume integration assigned to the products and 
the sum of the volumes of all the products in the lane. 
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APPENDIX ONE 
Polyamide-seco-CBI Conjugates to Study COX-2 and HIV-1 
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Abstract 
Described are the synthesis and characterization for seco-CBI polyamide 
conjugates to study inhibition of transcription elongation of COX-2 and to probe the 
cellular activity of transcription inhibition in HIV -1. Four compounds were studied for 
COX-2: fmmymy-EoF[lmmylm-EoFezky-mymymyozekymymymy-~-ap (1), fm-~-fmmymymy-
~Ok-fmmymymy-~-my-~-ap (2), fmmy-~-fmlm-~zk_mymy-~-fmmy-~-ap (3), fmmy-~­
fmmy-~zk_mymy-~-fmmy-~-ap (4). Two were studied for HIV-1 : fmmy-~-fmmy-ys>-CBf_ 
lmmy-~-fmmy-~-ap (5), and lmlm-~-lmlm-yR>-cs•_pymy-~-mymy-~-ap (6). Examination 
of the alkylation patterns of the polyarnides described offers insights into the design of 
future generations of this class of molecules. Further testing of these compounds in 
cellular assays will be performed shortly. We anticipate that those results will help us 
address new design considerations that may be necessary for future compounds in this 
series. 
Polyamides for Inhibition of COX-2 Transcription Elongation 
Background 
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In an inflammatory response, cyclooxygenase (COX) catalyzes the first 
committed step in arachidonic acid metabolism, eventually resulting in the formation of 
prostaglandins. There are two distinct COX enzymes, COX-I and COX-2. COX-1 is 
expressed in most tissues and is thought to release prostaglandins for the purposes of 
cellular housekeeping for maintaining organ and tissue homeostasis. COX-2 is expressed 
only in certain cells, such as fibroblasts and macrophages. It can be rapidly induced by 
cytokines or other mitogens. Inhibition of COX-2 relieves symptoms of inflammation, 
pain, and fever, while inhibition of COX-1 leads to side effects such as nausea and 
stomach pains. 
NSAIDs (nonsteroidal anti-inflammatory drugs) are inhibitors of COX, and 
include aspirin, ibuprofen, and naproxen. One problem with NSAIDs is a lack of 
specificity between the two COX enzymes. Often they inhibit both enzymes, resulting in 
both the alleviation of some symptoms and the onset of others. The crystal structures of 
COX- 1 and COX-2 show that the two enzymes are extrememly similar in overall 
structure, with an r.m.s deviation of 0.9 A for Ca atoms.' The most significant difference 
in the structures is within the binding pocket. An isoleucine in COX-1 is replaced by a 
valine residue in COX-2. Many of the newer NSAIDs try to take advantage of this larger 
binding pocket in COX-2 by making bulkier substituents which are sterically unable to fit 
in the COX -1 binding site.1.2 
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Experimental Design 
Prof. Harvey Herschman of UCLA was one of the early discoverers of COX-2,3 
and a collaboration with the Dervan group was started to see if Py-Im polyamides would 
be able to inhibit the induction of COX-2 by interfering with required transcription 
factors . We were also interested in looking at Py-Im polyamide conjugates with 
alkylating agents to see if transcription elongation of COX-2 could be inhibited by 
forming a covalent adduct with the DNA. Mr. Nicholas Wurtz from the Dervan group 
had already established a system of polyamide-nitrogen mustard conjugates that were 
promising as sequence specific DNA alkylating agents.4 Together, we designed a series 
of compounds to incorporate both the seco-CBI conjugates and the nitrogen mustard 
conjugates. 
The COX-2 gene is 6938 base pairs long, including the promoter (966 base 
pairs) . It contains ten exons, which comprise the 3985 base pairs of the COX-2 eDNA. 
From the complete gene sequence, we found four target sequences which occurred 
anywhere from twice to thirteen times within the coding region of COX-2, and also had 
an adenine proximal to the binding site (Figure 1). The Herschman group supplied us 
with a plasmid of the COX-2 eDNA, and we used fragments from the eDNA to 
determine the binding affinities of the unmodified parent polyamides. To minimize the 
number of fragments we had to label, we selected two fragments to examine, 198-496 
(numbering from eDNA sequence) and 500-772. Between the two fragments, they 
contain the binding sites of all four parent polyamides (Figure 2). 
(a) 
(b) 
Cox-2 Complete Gene 
6938 base pairs (including promoter) 
Promoter region 1-966 
10 exons 
I I II 
Cox-2 eDNA 
3985 base pairs 
5'-C C A G TAT A A G T G T G A C T-3' 
H3+ 
3 ' -G G T CAT AT T C A C A CT G A-5' 
3'-C C A C ACT T G T T A G-5 ' 
5'-A G T G C T G G A A A A G-3' 
~~+ 
3 ' - T C A C G A C C T T T T C-5' 
5' - A A AT TACT G C T G A- 3 ' 
+eP~
3' - T T T A AT G A C G A C T - 5' 
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1 2 sites 
1 site in eDNA 
2 5 sites 
2 sites in eDNA 
3 8 sites 2 sites in eDNA 
4 13 sites 6 sites in eDNA 
Figure 1. (a) Pictorial view of COX-2 gene. (b) Parent polyamides selected for this study, with number of 
sites in the COX-2 gene indicated. 
(a) 198-496: 
5'-ATGTCAhAACCGTGGGGbATGTATGAGCACAGGATTTGAC 
































Figure 2. Fragments of COX-2 eDNA used for this study. (a) 198-496, (b) 500-772. Boxes indicate the 
binding sites of the corresponding polyamide. Underlined sequence corresponds to the primers used for 
labeling studies. 
Results and Discussion 
Synthesis and Footprinting of Parent Polyamides 
Polyamides 1-4 were synthesized according to established solid phase synthesis 
protocols (Figure 3).5 Nicholas Wurtz performed the footprinting on compounds 1 and 
3, and I performed footprinting on 2 and 4. 
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Tandem polyamide 1 lmPyPy-(R)[ImPylm-(R)H2Ny-PyPyPy8]HNyPyPyPy-p-Dp, 
when measured on fragment 198-496 had an affinity of 4.0 x 109 at the site 5'-
AGTATAAGTGT-3.' We had anticipated that this compound would have a higher 
binding affinity, but were unsure of the generality of the tandem motif. When compared 
to the tandem lmPyPy-(R)[ImPyPy-(R)HzNy- PyPyPy8]HNyPyPyPy-p-Dp which bound the 
11 base pair sequence 5'-TGTTATTGTTA-3' with aKa of~ I x l012 M.1, the affinity of 
polyamide 1 is lower than expected.6 However, the binding affinity should be adequate 
for our purposes. 
Polyamide 2 fm-m-fmmymymy-~zk_fmmymymy-p-my-p-ap when measured on 
fragment 198-496 had an affinity of 2.3 x l010 M.1 at the sequence 5' -TGTGAACA-3. 
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This compares to the K. of~ 2.4 x 1010 M-1, that was reported for the compound fm-~-
fmmymymy-y-frnmymymy-~-my-~-ap at the same sequence.7 Polyamides 3 and 4 had 
binding affinities of L8 x 1010 M-1 and Ll x 1010 M-1, respectively, at the targeted match 
sites of 5' -TGCTGGA-3' for polyamide 3 and 5'-TACTGCT-3' for polyamide 4_ 
Synthesis and Thermal Cleavage Reactions of Polyamide Conjugates 
Because the footprinting experiments revealed that the polyamides bound to the 
designed target sequences, the polyamide seco-CBI conjugates lS and 3S were 
synthesized as previously reported (Figure 4).8 
15 
35 
Figure 4. Chemical structures of the polyamide conjugates used for the COX-2 study. 
Thermal cleavage reactions were performed for compound lS on fragment 198-
496 (Figure 5). Surprisingly, the alkylation gels showed that instead of alkylating 
proximal to the match site 5' -AGT AT AAGTGT -3', a strong alkylation site is observed 
proximal to the mismatch site 5'-TTCTATGGTGA-3 ' (mismatch underlined). The 
sequence requirements of the valerie acid linker have yet to be determined, so the G in 
the valerie acid linker region may or may not be a mismatch. At a minimum, this site is a 
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double base pair mismatch, and possibly a triple base pair mismatch. Alkylation at this 
site has a yield of 79% at 10 nM concentrations. No alkylation is observed at the adenine 
proximal to the match site. In addition to alkylating at a mismatch site, alkylation occurs 
three base pairs removed from the binding site of the polyamide, not the anticipated two 
base pairs. The reasons for this anomalous alkylation pattern shown for lS are unclear. 
One possibility is that the adenine proximal to the intended match site of lS is flanked by 
two G-C base pairs. The mixed sequence is not optimal for alkylation by CBI. However, 
the site that is alkylated by lS is flanked by an A-T tract, which is known to be a 
consensus sequence for the duocarmycins. This may be an instance where korr is slow at 
the match site, but k,1k is slower, resulting in no alkylation. Meanwhile, korr may be fast at 
the mismatch site, but k,1k is faster, yielding a strong cleavage site. 
Polyamide 3S was analyzed on fragment 500-772, and shows alkylation proximal 
to the expected match site 5'-TGCTGGA-3' (Figure 6). At 300 pM concentrations, the 
cleavage yield at this site is 83%. Again, an interesting observation is that the cleavage 
occurs at the adenine three base pairs removed from the binding site instead of two. The 
alkylated adenine is at the 3' side of a short A-T tract. It is known that A-T tracts bend 
toward the minor groove.9 Perhaps the bend in the DNA causes the unexpected 3' shift in 
alkylation. 
Future Work 
Due to problems generating reproducible and reliable results of inhibition of 
transcription initiation, work on this project has slowed. Once assays are available that 
can detect changes in protein or mRNA levels reproducibly, it will be interesting to see 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































without the biological assay results, it is worthy of note that for the two polyamide motifs 
in this study, both generally followed previous patterns of seco-CBI conjugates, and had 
high cleavage yields. 
Polyamide-Alkylator Conjugates that Target the Promoter Region of IDV -1 
Background 
Described previously were successful efforts to use Py-Im polyamides to inhibit 
binding of essential transcription factors to inhibit transcription of HIV -1. Two of the 
compounds used in that study were 5 and 6 (Figure 7a).10 Polyamide 5, ImPy-j3-ImPy-y-
ImPy-j3-IrnPy-j3-Dp, binds to the sequence 5'-WGCWGCW-3' with a Kd of0.05 nM. 
There are two match sites for polyamide 5 flanking the binding site ofT AT A Binding 
Protein (TBP) in the HIV- 1 promoter. Polyamide 6, Imlm-j3-Irnlm-y-PyPy- j3-PyPy- j3-Dp 
serves as a control compound and is a double base pair mismatch for the sequence 5 '-
WGCWGCW-3', and binds that site with a Kct of 5.0 nM. This study reported that 
polyamide 5 could inhibit TBP binding in vitro, while polyamide 6 could not. Inhibition 
of in vitro transcription by 50% was observed at 60 nM concentrations of polyamide 5, 
while no inhibition was observed for polyamide 6. Cell culture experiments indicated 
that polyamide 5 inhibited HIV - 1 viral replication by 80% at 1 j.!M concentrations, and 
polyamide 6 had no effect on viral replication. 
(a) 
5 -G C A A A A A G C A G C T G C T T A T A T G C A G C A T C T G A G-3 
~
3 -C G T T T T T C G T C G A C G A A T A T A C G T C G T A G A C T C-5 
5 TBP 5 
5 -G C A A A A A G C~q T A T A T G C A G C A ; C T G A G-3 
3 -C G T T T T T C G T C G A C G A A T A T A C G T C G T A G A C T C-5 
6 TBP 6 
(b) 
5 -G C A A A A A G C A G C T G C T T A T A T G C A G C A T C T G A G-3 
3 -C G T T T T T C G T C G A C G A A T A T A C G T C G T A G A C T C-5 
55 TBP 55 
5 
3 -C G T T T T T C T C-5 
65 TBP 65 
Figure 7. (a) Ball and stick model of the polyamidcs used for inhibition of HIV - I transcription initiation 
which inhibit binding ofTBP. (b) Proposed seco-CB! conjugates to target to HIV- 1 promoter. 
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A derivative of polyamide 5 modified with a nitrogen mustard has already been 
extensively characterized in the Dervan group by Nicholas Wurtz.4 It was found that the 
nitrogen mustard derivatized polyamide was able to alkylate the HIV -LTR promoter with 
good specificity and efficiency. Joel Gottesfeld of The Scripps Research Institute was a 
collaborator on the transcription inhibition studies of polyamides 5 and 6. He was 
interested in studying the nitrogen mustard analogues to confirm that polyamides are able 
to get to the nucleus and target their match sequence. By analyzing the cellular genomic 
DNA, he wanted to analyze the cleaved DNA resulting from the alkylation by the 
nitrogen mustard. To that end, we also designed seco-CBI polyamide conjugates of 
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polyamides 5 and 6 to compare to the results of the nitrogen mustard analogues (Figure 
7b). 
Synthesis and Thermal Cleavage Assays 
Polyamides SS and 6S were synthesized as previously described (Figure 8).5·8 
They were analyzed on a 241 base pair fragment containing the HIV-LTR promoter 
(Figure 9) . 
Figure 8. Chemical structures of the seco-CBI polyamide conjugates used for the HIV-1 study. 
pHIV-LTR restriction fragment (241 bp) 
5'-AATTCGAGCTCGGTACCCGGTAACCAGAGAGACCCAGTACAGGCAAAAAGCAGCTGCTTATATGCAGCATCTGAGGGACG 





Figure 9. HIV-LTR restriction fragment used in this s tudy. Polyamide binding sites are underlined and 
TBP binding site is indicated in bold. 
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Polyamide SS shows alkylation proximal to the binding sites flanking the TAT A 
box (Figure 10). At the match site to the right of the TATA box, 5'-TGCAGCA-3 ', 
polyamide SS shows alkylation at two adenines. It is a bit unusual that alkylation is seen 
at adenines so far from the polyamide binding site, but may be explained because the 
TAT A box is known to be bent toward the minor groove.9 The cleavage yield at this site 
is 45% at I nM concentrations of SS. The binding site to the left of the TAT A box is 
actually two overlapping match sites, 5' -AGCAGCTGCT -3'. Here a high yielding 
cleavage site (62% at 10 nM) is observed along an A-T tract. Another alkylation site at 
theTA T A box is observed for another binding mode of the polyamide. This site has a 
lower cleavage yield of 12% at 3 nM concentrations. 
Despite being designed as a mismatch, polyamide 6S cleaves the same fragment 
at almost identical adenines with comparable or higher cleavage yields (Figure 11 ). 
Again, this may be a situation where the equilibration of the polyamide off of a mismatch 
site (k0 rr) is slower than the alkylation reaction of seco-CBI at N3 of adenine (k,1k). The 
A-T tracts that flank the polyamide binding sites are known to be preferred alkylation 
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Comparison with Nitrogen Mustard Polyamide Conjugates 
Figure 12 compares the alkylation sites seen with the polyamide seco-CBI 
conjugates and the nitrogen mustard conjugates. The nitrogen mustard analogue of 
polyamide 6 showed no alkylation at all on this fragment. Comparing SS and its nitrogen 
mustard counterpart, at the binding site on the left side of theTA T A box (Figure 12a), the 
nitrogen mustard analogue alkylates preferentially at the TAT A box, and shows no 
alkylation at the A-T tract. Meanwhile, SS shows the majority of cleavage at the A-T 
tract. At the binding site to the right side of the TAT A box (Figure 12b ), polyamide SS 
displays DNA cleavage at the TAT A box, as does the nitrogen mustard analogue. The 
nitrogen mustard analogue also shows alkylation at an adenine on the opposite side of the 
TAT A box for the other polyamide binding mode. 
The differences between the nitrogen mustard polyamide conjugates and the seco-
CBI conjugates are noteworthy. As DNA alkylating agents, nitrogen mustards prefer to 
alkylate in the major groove at N7 of guanine, but will react with N3 of adenine in the 
minor groove when directed by a minor groove binding ligand. 11·12 Conversely, 
duocarmycins target the N3 of adenine, and react preferentially there. The differences 
observed in the alkylation patterns most likely result from the different reactivity of the 
alkylating agents. The results indicate that at particularly reactive sites for seco-CBI, 
alkylation occurs more quickly than equilibration from a mismatch site. Meanwhile, for 
the nitrogen mustard conjugates, because the reactivity is slower at N3 of adenine, it 
waits for the polyamide to equilibrate to a match site and then alkylates DNA if an 
adenine is available. So, decreased rate of alkylation actually allows for increased 
specificity of alkylation. 
(a) 
5'-AAAAAG 
3'-T T T T T C 
5'-AAAAAG 
3' -T T T T T C 
c T D A TAT G c A G cAT C-3' 
G A A T A T A C G T C G T A G-5' 
t 
(b) 
Figure 12. Ball and stick models that compare the alkylation of seco-CBI polyamide conjugates with 




Currently, these seco-CBI conjugates have been sent to the Gottesfeld group and 
we look forward to seeing how these molecules react in cells. 
The investigation of seco-CBI conjugated to polyamides of different sequence and 
motif suggests additional factors that influence reactivity of such compounds. When 
designing such compounds to address a particular application, the sequence specificity 
and affinity of the Py-Im polyamide will always be of primary importance. However, the 
kinetics of polyamide binding also affect the specificity of such conjugates, because of 
their fast on rates to DNA, and slow off rates. 13 The sequence context of the binding site 
in question should not be overlooked. In the case of seco-CBI conjugates, it appears that 
flanking sequences and the reactivity of target alkylation sites greatly affect the efficiency 
and predictable nature of DNA alkylation. Those things can be taken into consideration 




1H NMR spectra were recorded on a General Electric-QE NMR spectrometer at 300 MHz 
with chemical shifts reported in parts per million relative to residual solvent. UV spectra 
were measured in water on a Hewlett-Packard Model 8452A diode array 
spectrophotometer. Matrix-assisted, laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF) was performed at the Protein and Peptide Microanalytical 
Facility at the California Institute of Technology. Preparatory reversed phase HPLC was 
performed on a Beckman HPLC with a Waters DeltaPak 25 x 100 mm, 300 A C18 
column equipped with a guard, 0.1% (wt/v) TFA, 0.25% acetonitrile/min. 
Synthesis of CBI-polyamide conjugates 
fmmymy-EoF[fmmylm-EoF"Oky-mymymyoz"kymymymy-~-ap (1). ImPyPy-(R)[ImPylm-
EoFeOky-mymymyozekymymymy-~-mam resin was synthesized in a stepwise fashion by Soc-
chemistry manual solid phase protocols by Nicholas Wurtz. A sample of resin was treated 
with neat (dimethylamino)-propylamine (2 ml), heated (55 ·c, 24 hours) and purified by 
reversed phase HPLC. lmmymy-EoF[fmmylm-EoFezky-mymymyoz"kymymymy-~-ap was 
recovered as a white powder upon lyophilization of the appropriate fraction. UV (H20) 
Amax (c), 312 nm, (99, 900); MALDI-TOF-MS (monoisotopic) [M+H] 1910.97 (calculated 
1909.97 for C91 H 111N330.6). 
lmmymy-EoF[fmmylm-EoFc1uKkesy-mymymyoz"kymymymy-~-ap (1-DSG). 1-DSG was 
prepared by already published methods.8 UV (H20) A.max (c), 312 nm, (99, 900); MALDI-
TOF-MS (monoisotopic) [M+H] 2122.25 (calculated 2120.94 for C99H 12oN340 2 1). 
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ImPyPy-(R)[ImPylm-(RY5>-co•y-pypypyo]HN)'PyPyPy-p-Dp (IS). IS was prepared by 
already published methods.8 UV (H20) A.max (£), 312 nm, ( 107, 154); MALDI-TOF-MS 
(monoisotopic) [M+H] 231 L12 (calculated 2310.01 for C 111 H132ClN350 20). 
Im-P-ImPyPyPy-(R)H2Ny-ImPyPyPy-p-Py-p-Dp (2). 2 was prepared in an analogous 
fashion to I. UV (H20) "-max (E), 312 nm, (83, 250); MALO I-TOF-MS (monoisotopic) 
[M+H] 1624.88 (calculated 1623.75 for C75H93N290 14). 
ImPy-P-Imlm-(R)H2N)'-PyPy-p-ImPy-p-Dp (3). 3 was prepared in an analogous fashion 
to I by Nicholas Wurtz. UV (H20 ) "-max (E), 312 nm, (66, 600); MALDI-TOF-MS 
(monoisotopic) [M+H] 138L75 (calculated 1380.64 for C62H8oN260 12). 
ImPy-p-Imlm-(R)G1u-NHsy-PyPy-p-ImPy-p-Dp (3-DSG). 3-DSG was prepared in an 
analogous fashion to I-DSG from 3. UV (H20) A.max (E), 312 nm, (66, 600); MALDI-
TOF-MS (monoisotopic) [M+H] 1592.75 (calculated 159 L69 for C7 1H89N270 17) . 
ImPy-P-Imlm-(R)<s>-co•y-PyPy-P-ImPy-p-Dp (3S). 3S was prepared in an analogous 
fashion to IS from 3-DSG. UV (H20 ) "-max (E), 312 nm, (73, 854); MALDI-TOF-MS 
(monoisotopic) [M+H] 178L94 (calculated 1780.76 for C83H 10 1ClN280 16). 
ImPy-P-ImPy-(R)H2Ny-PyPy-P-ImPy-p-Dp (4). 4 was prepared in an analogous fashion 
to I. UV (H20 ) "-max (E), 312 nm, (66, 600); MALDI-TOF-MS (monoisotopic) [M+H] 
ImPy-P-ImPy-(R)H2Ny-ImPy-P-ImPy-p-Dp (5). 5 was prepared in an analogous fashion 
to I. UV (H20 ) "-max (E), 312 nm, (66, 600); MALDI-TOF-MS (monoisotopic) [M+H] 
ImPy-P-ImPy-(R)G1u-NHsy-ImPy-p-ImPy-p-Dp (5-DSG). 5-DSG was prepared in an 
analogous fashion to I-DSG from 5. UV (H20 ) "-max (E), 3 12 nm, (66, 600). 
103 
ImPy-t3-ImPy-(R)"2Ny-ImPy-j3-ImPy-j3-Dp (SS). SS was prepared in an analogous 
fashion to 1S from 5-DSG. UV (H20) A,ax (c:), 312 nm, (73, 854); MALDI-TOF-MS 
(monoisotopic) [M+H] 1781.9 (calculated 1780.76 for C83H 101 ClN280 16). 
Imlm-j3-Imlm-(R)"2Ny-PyPy-j3-PyPy-j3-Dp (6). 6 was prepared in an analogous fashion 
to 1. UV (H20) "-max (£), 312 nm, (66, 600); MALDI-TOF-MS (monoisotopic) [M+H] 
1381.76 (calculated 1380.64 for C62H80N260 12). 
lmlm-j3-Imlm-(R)c1u·NHSy-PyPy-j3-PyPy-j3-Dp (6-DSG). 6-DSG was prepared in an 
analogous fashion to 1-DSG from 6. UV (H20) ~nax (£), 312nm, (66, 600). 
Imlm-j3-Imlm-(R)<sJ-CBty-PyPy-j3-PyPy-j3-Dp (2R). 2R was prepared in an analogous 
fashion to 1S from 6-DSG. UV (H20) "-max (c:), 312nm, (73, 854); MALDI-TOF-MS 
(monoisotopic) [M+H] 1781.73 (calculated 1780.76 for C83H 10 1ClN280 16). 
DNA Reagents and Materials. Enzymes were purchased from Boehringer-Mannheim 
and used with their supplied buffers. Deoxyadenosine 5 ' -[y-32P] triphosphates were 
purchased from I.C.N. Sonicated, deproteinized calf thymus DNA was acquired from 
Pharmacia. RNase free water was obtained from USB and used for all reactions. All 
other reagents and materials were used as received. All DNA manipulations were 
performed according to standard protocols. 
Construction of Plasmid DNA. The eDNA plasmids of COX-2 were provided by the 
Hersch man group of UCLA. The HIV -L TR plasmid was provided by the Gottesfeld 
group at Scripps. The particular plasmid used was prepared by Nicholas Wurtz and 
contains two mutations that differ from the original plasmid (See notebook 9, page 141 
for sequence). Concentration of the prepared plasmid was determined at 260 nm from 
the relationship of 1 00 unit=50 1-1g mL-1 duplex DNA. 
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PCR Labeling to generate 5'-End-Labeled Restriction Fragments. To label COX2-
198-496 fragment, primers 5'-ATGTCAAAACCGTGGGGAATG-3' and 5'-
AGCTTTTGTAACCATAGTGCA-3' were used. For COX-2 fragment 500-772, primers 
5' -AAGCCTTCTCCAACCTCTCCT -3' and 5'-TT AAGTCCACTCCA TGGCCCA-3 ' 
were used. To 5' label the HIV-LTR promoter, primers 5'-AATTCGAGCTCGGTACCC 
GGT-3 ' (labeled) and 5'-TGCATGCCTGCAGGTCGATTG-3' (unlabeled) were used. 
Depending on the strand to be labeled, one primer was treated with T4 polynucleotide 
kinase and deoxyadenosine 5' -[y-32P] triphosphate as previously described. PCR 
reactions containing 60 pmol each primer, 10 f.ll PCR buffer (Boehringer-Mannheim), 3.7 
f.ll template (0.003 f.lg/mL), 2 f.ll dNTP mix (each at 10 mM), 1 f.ll lOOX BSA (New 
England Biolabs) and 83 f.ll water were heated at 70 oc for 5 minutes. Four units of Taq 
Polymerase were added (Boehringer-Mannheim). Thirty amplification cycles were 
performed, each cycle consisting of the following segments: 94 OC for 1 minute, 54 OC 
for 1 minute, and 72 OC for 1.5 minutes. Following the last cycle, l 0 minutes of 
extension at 72 OC completed the reaction. The PCR products were gel purified as 
previously reported for 3' -end labeling protocols. 
Preparation of 3' -End labeled Restriction Fragments. The HIV -LTR plasmid was 
linearized with EcoRI and then treated with Sequenase enzyme, deoxyadenosine 5' -a-
32P-triphosphate, and thymidine triphosphate for 3' labeling. Treatment with Hindlll 
generated the desired 241 base pair fragment which was isolated as previously described. 
Cleavage Reactions. All reactions were carried out in a volume of 50 f.ll. A polyamide 
stock solution or water (for reference lane) was added to an assay buffer ofTE (pH7.5) 
and 20 kcpm of3'- or 5'-radiolabeled DNA. The solutions were allowed to equilibrate 
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for 12 hours or the appropriate time (for time course reactions) at 37 OC. The reactions 
were stopped with 60 fll of a solution containing NaOAc (600 mM), EDTA pH 8.0 (12.5 
mM), calf thymus DNA (150 fJM base pair), glycogen (0.8 mg mL-1), and NaCl (2M). 
Ethanol was added to remove unbound polyamide and precipitate the products. The 
reactions were resuspended in 20 fll of TE (pH 7 .5) and cleavage was initiated by heating 
at 95 OC for 30 minutes. The cleavage products were precipitated with 150 fll ethanol and 
then resuspended in 100 mM trisborate-EDT A/80% formamide loading buffer, and 
denatured and loaded onto polyacrylamide gels as previously reported. The gels were 
quantitated by the use of storage phosphor technology. Yield or efficiency of alkylation 
was determined as the ratio between the volume integration assigned to the products and 
the sum of the volumes of all the products in the lane. 
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